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This section
provides a medium through which Canadian
surgeons can declare themselves, briefly and in
formally, on the day-to-day affairs of surgery.
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MECHANICS OF URETERAL
DILATATION
Treatment of abnormalities that result
in ureteral dilatation is often based on the
static picture obtained from the intra
venous urogram. In an article elsewhere
in this issue (page 4), Tanagho has shown
experimentally that ureteral structure and
function change with different degrees of
dilatation and also that these changes vary
in different segments. Thus, effective treat
ment must be based on a knowledge of
these differences.
Appreciation of variations in the ureteral
wall is particularly important in surgical
repair of the ureterovesical junction, where
techniques that discard the abnormal termi
nal segment are preferable to those that re
tain it. Tailoring procedures reduce the di
ameter of the ureter but will not improve
flow if the peristaltic function of the wall
has already been destroyed by overstretch
ing or infection. Revision of the ureteral
orifices in the “prune-belly” syndrome will
not decrease ureteral dilatation and stasis
because the orifices are not obstructive;
the defect that allows dilatation is in the
ureteral wall itself.
Again, fundamental observations in the
laboratory have led to more rational clini
cal procedures.
F rank H inman, J r .

*
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EDITORIAL COMMENT

University of California
School of Medicine,
San Francisco, Calif., U.S.A.

SELECTION FOR LUNG CANCER
SURGERY
Lung cancer is now the most common
cancer in the adult male and is rapidly
increasing in frequency in the female
population. The long-term results of treat
ment are still poor, with a 13% five-year

survival rate, but it has now become
possible to select the patients for operation
in such a way that of those operated upon,
96% are resectable with almost 40% fiveyear survival. By such selection, only those
with a good chance of cure are operated
upon; those patients refused operation are
rejected on the basis of a tissue diagnosis
of inoperability. This major change in the
practice of thoracic surgery has taken
place in the last 10 years.
Selection for surgery is based upon
history and physical examination, radiologic examination, liver function studies,
pulmonary and cardiac function and, to a
large extent, upon bronchoscopy and medi
astinoscopy.
On history alone, the physician may
strongly suspect metastatic spread of
bronchogenic carcinoma to brain, bones,
liver, skin or esophagus. Further investiga
tion of these sites may confirm or deny
the presence of carcinoma.
Local spread may be noted on physical
examination, with the findings of pupil
changes in the eye or anhydrosis of the
face, nodal spread in the neck or superior
vena caval obstruction.
More specific investigation of the lung
lesion can be carried out radiologically.
Standard chest films are the most useful
examination in locating the lesion and de
termining potential areas of local spread.
Tomography is of value in defining the
lesion, looking for calcification and deter
mining local bone spread. Bronchograms
are not often used but have a place in con
firming peripheral bronchial obstruction if
the diagnosis is in doubt. Pulmonary angio
graphy gives accurate assessment of pul
monary arterial involvement in centrally
placed tumours, and is also useful in de
termining minor degrees of superior vena
caval obstruction. Barium swallow is used
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to determine esophageal spread of the dis
ease and this information can be further
supplemented by esophagoscopy and medi
astinoscopy.
Routine laboratory studies should in
clude an assessment of liver function, en
zyme determinations like alkaline phos
phatase, SCO T and BSP studies. When in
doubt, liver needle biopsy may obtain a
tissue diagnosis of liver spread. Liver
scans are inaccurate and give too many
false positive results to be of much value.
If liver metastases cannot be excluded, a
small laparotomy with inspection and
biopsy of suspicious lesions is sometimes
the only effective method of excluding
metastatic disease.
Bronchoscopy and mediastinoscopy are
the two most accurate methods of assess
ing local operability of the tumour. Bron
choscopy allows biopsy and tissue diag
nosis of main-stem bronchial carcinoma.
Bronchoscopy alone may show an inoper
able situation if the trachea or tracheal
carina are involved by tumour.
Mediastinoscopy gives access to the
lymph nodes at both tracheobronchial
angles, in the anterior subcarina and in the
subinnominate space. Biopsy of these
nodes will allow an accurate tissue diag
nosis of the spread of the disease. At medi
astinoscopy, the exact location of nodes
should be recorded because location is of
prime importance in determining opera
bility.
Mediastinoscopy is critical in determin
ing operability and, hence, should be done
by the surgeon who is going to do the
resection.
Inaccurate
mediastinoscopic
findings may result in unnecessary thorac
otomy and, furthermore, the operation of
mediastinoscopy is difficult to repeat and
is less accurate on the second occasion.
Most patients who have mediastinal
lymph-node involvement are considered in
operable. At present in the Division of
Thoracic Surgery, Toronto General Hos
pital, we are assessing the results of re
section after 3500 rads of radiation given
over three weeks in a small group of pa
tients with favourable malignancy and
small nodal metastases at the tracheo
bronchial or in the anterior subcarinal
lymph nodes. It is too early to assess fully

Vol. 15

the results of this approach but early
results are encouraging.
Anterior mediastinoscopy, done through
a two-inch anterior incision in the second
interspace, allows the surgeon to assess
further the local spread of the disease. This
procedure is of particular value in left
upper lobe carcinoma, which character
istically spreads to the anterior medi
astinum and may be missed by the stand
ard mediastinal approach.
As a routine, all of our patients are
assessed by history, physical examination,
laboratory studies, bronchoscopy and medi
astinoscopy. Additional studies are used
only as indicated, to clarify particular
tumour invasions. This investigation de
termines operability in terms of tumour
spread, but does not determine the pa
tient’s ability to withstand operation.
Age is no longer a contraindication to
lung surgery if the patient is mentally
and physically healthy. Lobectomy in a
healthy person can be tolerated even in
80-year-old
patients.
Pneumonectomy,
especially right pneumonectomy, places a
greater strain on cardiac function and
should be done on patients over the age of
70 years only after careful assessment.
Heart disease is not often the major
contraindication to surgery for lung can
cer, but recent myocardial infarct (under
three months), severe angina or advanced
cardiac failure are contraindications.
Impaired pulmonary function is much
less of a contraindication than we once
believed. The surgeon always estimates the
volume of true functioning lung he is re
moving in contrast to the total mass of
lung removed. Severe respiratory distress
is not a contraindication if the lung being
excised is already totally destroyed and,
indeed, many such distressed patients im
prove markedly when an obstructed in
fected lung is removed. However, it is
difficult to make precise correlation be
tween pulmonary function and operability.
The surgeon must exercise good judgment
after assessing the patient’s past pulmonary
function, his present exercise tolerance,
blood gases and pulmonary function
studies. Specific lobar and whole-lung
function can be investigated by bronchospirometry, angiography and zenon scan-
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ning, to determine the actual function of
the portion of lung to be removed and the
anticipated residual lung function.
Careful preoperative physiotherapy and
antibiotic therapy may greatly improve
the patient’s exercise tolerance and may
control respiratory tract infection both
before and after operation.
In our experience, accurate assessment
of resectability and careful selection of pa
tients for lung cancer surgery have steadily
improved the five-year survival rate in this
disease. In addition, assessment of pul
monary and cardiac function and careful
preoperative and postoperative manage
ment have steadily lowered the postopera
tive mortality rate.
R. D. H enderson

Toronto General Hospital,
Toronto, Ont.
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EDITORIAL COMMENT

addition, we forget at times that the indi
vidual who writes review articles must
bring to this task extensive communica
tion skills. He must combine criticism,
analysis and synthesis—scholarly attributes
of a high order. For this reason, the scien
tific community cannot or, at least, should
not delegate the writing of these reviews
to the newcomer, to the youngest member
of the team. Departmental chairmen know
which of their staff have reached a point
where they can prepare a review: all that
remains is for them to pursue the matter
(and the author) to a successful conclusion.
As C. G. Roland, Chairman, Department
of Biomedical Communications at the Mayo
Clinic, points out “science in an unbeliev
ably productive era for all its components,
continues to condone the appallingly in
adequate style of communication which
debases so many of our journals and
books. As a consequence, the need for
communication increases at an unprece
dented rate, while the oral and written
literacy of newly trained professionals
seems to decrease each year.”2 However,
a much more serious malady seems to
underlie our communications difficulties—
the disease of indifference. Bentley Glass
has remarked that scientists overemphasize
the importance of laboratory or field tech
nique and underemphasize or underesti
mate the importance of the communica
tion of ideas. In addition, many scientists
seem not to care about expressing them
selves clearly, and, as long as otherwise re
putable journals continue to publish badly
presented articles, there is no pressure on
the author to improve. The author need
not go through the painful business of
struggling to communicate well when he
can pass the burden on to his readers. As
Roland reminds us “The equation makes
scant sense, and the outcome may be
serious indeed. If one part of science—the
preparation of the ‘literature’—can be done
shoddily without penalty, will the same
attitude of indifference not come to affect
the rest of the scientific effort?”
J. O. G odden

REVIEWS OF EXPERIENCE
Special advantages accrue to the writer
of scientific reviews. First, the acceptance
of this responsibility forces him to sort the
lumber in his intellectual attic and evalu
ate anew the basic concepts in his chosen
field. Even if his paper is not published
or, if published, is read only by a few of
his colleagues, he will still gain much by
his effort. Second, a good review article
makes a real contribution to the education
of a physician’s peers, the students of his
time and to his posterity. Recently, when
discussing this subject, R. Ian MacDonald,
a distinguished clinician and teacher,
drew attention to the central place in
medical education of such reviews as
F. R. M. Walshe’s “Intracranial Tumours:
A Critical Review”.1 Every teacher can
cite one, several or many such papers that
have been milestones on his road to pro
fessional competence.
However, as any editor will testify, re
view articles are hard to come by. That
we have survived till now without provid
ing a reliable mechanism of insuring peri
odic reviews of current progress does not
make this problem any less important.
Furthermore, although our system provides
funds to promote the collection of data 1.
on a large scale, it provides little to 2.
support the analysis of the same data. In

R efe ren ces

W alshe FR: Intracranial tumours: critical
review. Q ] Med 24: 587, 1931
R oland CG: Personal view. Br Med J 3: 301,
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REVIEW ARTICLE

MECHANICS OF URETERAL DILATATION*
EMIL A. TANAGHO, M.D., M.Ch., San Francisco, Calif., U.S.A.

The dilated ureter is a major problem in
urologic surgery. Although the mechanism
of dilatation in the presence of organic
obstruction is clearly understood, its
mechanism in several other pathologic
situations is either controversial or inade
quately explained.

Observations accumulated from experi
mental and clinical studies on normal and
pathologic ureters are clarifying the etiol
ogy and mechanism of specific types of
ureteral dilatation. Herein I will attempt to
tie these observations together, relating
embryologic and myogenic features of the
ureter to the etiology and pathology of
dilatation.

dorsomedial aspect of this cellular pro
liferation. The outpouching then grows
cranially to meet and unite with the metanephric cap; at the same time the common
nephric duct is absorbed into the uro
genital sinus and the ureteral bud gains an
independent opening into the urogenital
sinus.
Condensation of loose mesenchyme
around the ureteral bud marks the start of
its muscularization and can usually be
noted as early as the 26-mm. stage (late in
the eighth week).1-2 Initially, the young
mesenchymal cells have a circular orienta
tion around the ureteral bud. Later, longi
tudinally oriented fibres are seen. There is,

*

Fig. 1.—Longitudinal section through the intravesical ureter showing the purely longitudinal
orientation of ureteral muscles. Note the meeting of the ureteral roof and floor fibres at the level of
the ureteral orifice as ureteral musculature continues to form the superficial trigone (Trichrome stain
X 25).

however, no layering of this mesenchymal
tissue. Differentiation of these mesenchy
mal cells into muscle fibres determines the
ureteral muscle coat. Hypothetically, if the
developing ureter elongates, the circularly
oriented mesenchymal cells (which at this
phase are differentiating into muscle fibres)
will assume an increasingly longitudinal
orientation. If the ureter mainly widens,
the muscle fibres differentiating from these
mesenchymal
cells will assume a more ac
"From the Division of Urology, University of Cali
fornia School of Medicine, San Francisco, Calif. centuated circular orientation. There is ex-

V

E m b b yo lo g ic F eatures

The ureter develops as an outgrowth of
the mesonephric duct at the end of the
fourth week of embryonic life. Close to its
caudal end, where it bends to open into the
cloaca, the mesonephric duct develops a
localized thickening by cellular prolifera
tion around its circumference. The ureteral
bud first appears as an outpouching of the

*
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Fig. 3.—T 1 e effect of widening and lengthening
at the urf eropelvic junction, resulting in a
funnel-shap d appearance.

preponderance of circularly oriented fibres
(Fig. 2 ). Widening of the cranial end of
the ureteral bud, if associated with little or
no longitudinal stretching at this level,
produces a sharp transition between a wide
box-shaped, pelvis and a normal-calibre
ureter.8 However, if the widening is as
sociated with some longitudinal stretching,
the outcome will be the commonly en
countered
funnel-shaped
ureteropelvic
junction, which is definitely more desirable
hydrodynamically (Fig. 3 ).
Fig. 2.—Longitudinal section of the pelvic wall,
showing an abundance of circularly oriented fibres
(Trichrome stain X 7).

perimental evidence that intrauterine sur
gical intervention at various phases in the
development of the fetal ureter has in
duced and/or prevented these anatomic
changes.3
Normally, the ureter overall grows more
in length than in breadth, thereby produc
ing an almost equal mixture of fibre orien
tation.4'7 However, rate and direction of
growth are not uniform and at both ends
the ureter undergoes different specific
changes (Fig. 1). The terminal part of the
ureter (the intravesical ureter) has a purely
longitudinal muscle arrangement, whereas
the proximal part (the renal pelvis) has a

M yo g e n ic F eatures

The ureter has only one muscle coat in
contrast to the layering seen in other
smooth muscle tubes. As a result of the
lengthening, stretching, and rotation of the
developing ureteral bud, each ureteral
muscle bundle assumes an irregular helical
orientation. The combination of several
helical bundles results in the commonly
seen ureteral muscle arrangement where
fibres run in all directions (Fig. 4 ).4-7 In
the terminal ureter, however, the helical
loops open widely, and the fibres assume a
purely longitudinal orientation (Fig. 1).
The terminal ureter loses its lumen at the
ureteral orifice and continues uninterrupted
into the trigone.9 This arrangement offers
an efficient adaptable sphincteric mecha-

6
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nism at the ureterovesical junction that
guards against regurgitation of urine from
the bladder and at the same time gives
minimal resistance to the flow of urine
from the ureter to the bladder.

Fig. 5.—Intravenous pyelogram of a 7-year-old
boy with diabetes insipidus. Note the wider
ureteral lumen, with no evidence of stasis.

E tiology
Factors leading to ureteral dilatation
may be physiologic or pathologic.
Physiologic factors are intermittent; when
the predisposing factor is relieved, the
ureter regains its normal calibre. Usually
there is only ureteral dilatation with no
lengthening.
Diuresis is a common physiologic factor
and is encountered frequently because of
the increasing use of infusion pyelograms
and angiograms. The ureter is capable of
transporting a limited volume per unit of
time.10 This volume is more than three or
four times the average normal urinary out
put. Within this volume range, the ureter
will vary its calibre and diameter by using
its reserve capacity—dilating without
lengthening.11 The ureteral segment that
limits emptying ability is the narrowest
least-stretchable segment and the one with
the highest resistance—the intravesical
ureter. If urine output exceeds ureteral
emptying ability, pathologic stretching oc
curs. Urine output normally is not constant,
and the ureter is able to handle normal
diurnal variations in urinary output as well
as phases of physiologic diuresis.12’ 13 How
ever, in cases of pathologic sustained
diuresis (as in diabetes insipidus), the
ureter may give way and remain dilated14
(Fig. 5 ), or in a sense adjust itself to the
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mmHg.
IN TRAVESICAL

PRESSURE

_________________________
Fig. 6.—Simultaneous recording of intravesical pressure and resistance to flow through the intra
vesical ureter during bladder filling and voiding. Note the minimal rise in intravesical pressure with
filling, yet the marked rise in resistance to flow. At the end of filling, resistance to flow was about
75 mm. Hg although intravesical pressure was only 25 mm. Hg. There was an even sharper rise
(over 150 mm. Hg) during voiding although intravesical pressure was only 40 mm. Hg. (Reproduced by
permission from Tanagho EA, Hutch JA, Meyers FH, et al: Primary vesicoureteral reflux: experimental
studies of its etiology. J Urol 93: 165, 1965.)

added load by constantly filling and
stretching, thus adding to its reserve capac
ity. The ureter adapts itself to this over
load, and in most instances the degree of
ureteral dilatation, although significant, is
not progressive over the years. During
diuresis, although stasis may be interpreted
from the pyelographic appearance, the
ureter is constantly transporting its con
tents at a maximal flow rate and is filling
as fast as it is emptying.
In a normal voiding cycle, progressive
bladder filling and distension cause a pro
gressive increase in the resistance of the
intravesical ureter, leading to ureteral
stasis and dilatation15 which will be re
lieved immediately after voiding and
bladder emptying. During bladder disten
sion, the resistance to flow in the intra
vesical ureter can be as high as 60 to 80
mm. Hg, which is far beyond ureteral
contractility (Fig. 6). The obstructing
mechanism is not the intravesical pressure
which is usually within the range of 10 to
20 mm. Hg during bladder filling. Rather
the stretched trigone firmly occludes the
intravesical ureter and thus increases its
resistance to flow.15
Other physiologic factors in ureteral di
latation are hormonal effects, seen in
pregnant women16’ 17 or in those using
contraceptive pills.18 The mechanism is
probably relative hypotonia with resultant

ureteral dilatation, enormously increasing
reserve capacity with minimal ureteral
lengthening.
Pathologic factors leading to ureteral di
latation are numerous. Impacted stones,

Fig. 7.—Voiding cystourethrogram showing bi
lateral reflux in markedly dilated tortuous ureters.
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tumours, intrinsic ureteral stricture, and
ureteral compression by a nearby mass are
clearly mechanical encroachments on the
ureteral lumen that impede transport and
result in ureteral dilatation and length
ening. However, in other instances, the
mechanics of obstruction are not clear.
In ureteral dilatation associated with
vesicoureteral reflux (Fig. 7) there is no
organic narrowing in the ureter and
drainage at first is perfect. The mechanics
of dilatation are primarily: (1 ) the ureter
is overstretched repeatedly to a degree that
depends on the volume of refluxing urine;
(2 ) the ureteral wall is subjected to higher

Vol. 15

bearing on the ability of such a ureter to
recover.
Ureteral dilatation commonly develops
also as a result of infravesical obstruction
or neurogenic bladder dysfunction in spite
of the presence of a competent uretero
vesical junction. In these instances, resting
intravesical pressures are normal20 yet
voiding pressures are high. Since the
ureterovesical junction is competent, these
pressures are not transmitted to the upper
urinary tract. Detrusor thickening was
partly blamed for strangulation of the
intravesical ureter and the ureteral obstruc
tion. Our studies, however, implicate tri

v
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<
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Fig. 8.—Intravenous pyelogram (IVP) of a patient with obstructive benign prostatic hyperplasia.
(A ) Two-hour film showing marked bilateral hydronephrosis with seriously impaired function on the
left side. (B) Intravenous pyelogram 10 days after catheter drainage showing marked regression in the
degree of ureteral dilatation with improvement in ureteral drainage and kidney function. (C) Cystogram showing no reflux. (D) Intravenous pyelogram two weeks later after transurethral resection show
ing improvement and regression of the dilatation.

pressures—both resting intravesical pres
sure and the much higher voiding pressure
—and usually progressively gives way and
dilates; (3 ) the ureter must transport an
increased volume equal to the urine output
plus the refluxing urine; (4) an intrinsic
ureteral feature aggravates these three
other factors and leads to further ureteral
dilatation and tortuosity: the refluxing
ureter, especially in severe cases, is usually
congenitally muscularly deficient to a
variable degree,19 which limits its ability
to resist higher pressures and increased
volume. The ureter cannot respond as a
normal ureter by showing hypertrophy and
by developing more muscle mass and tone
to counteract these adverse hydrodynamic
changes. This same phenomenon has a

gonal hypertrophy ( always present in these
instances) as the primary factor increasing
resistance.21 Stretching of the hyper
trophied trigone by the residual urine
that is commonly present aggravates this
obstructive mechanism even more. Simple
bladder drainage will relieve this stretch
ing and minimize the resistance at the
intravesical ureter (Figs. 8 and 9 ). Tri
gonal irritation and spasm from pro
longed use of catheters or suprapubic tubes
can lead to a similar obstructive phenome
non.15' 20
A puzzling entity of ureteral dilata
tion is the obstruction encountered in the
absence of any of the previously mentioned
causes. The terminal ureter is the com
monest site of such an obstructive phe-
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Fig. 9.—(A) Intravenous pyelogram o f a patient with neurogenic bladder with large residual and
showing marked bilateral dilatation. (B) Intravenous pyelogram 24 hours after catheter drainage. Note
the regression in the degree of ureteral dilatation because of the release o f trigonal stretch.

nomenon, with dilatation of the pelvic
ureteral segment that may extend to in
clude the entire upper urinary system ( Fig.
10). Several etiologic factors have been

incriminated, e.g. aperistaltic segment,
achalasia o f the ureter, similar to Hirsch
sprung’s disease with lack of ganglion cells
and persistence o f
Schwalla’s mem-

Fig. 10.—(A) Delayed IVP of a patient with functional ureteral obstruction with massive hydro
ureter and hydronephrosis. (B) Surgical exploration showing the dilated ureter tapering to normal juxtavesical ureter. (C) Intravenous pyelogram four months after ureteral tailoring and reimplantation. (Repro
duced by permission from Tanagho EA, Smith DR, Guthrie TH: Pathophysiology o f functional ureteral
obstruction. J Urol 104: 73, 1970.)
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Fig. 11.—(A) Cross-section of intravesical ureter shown in Fig. 10. Note the normal purely
longitudinal muscular arrangement. (B) Cross-section of the functionally obstructive juxtavesical ureter
with almost purely circular muscular orientation (Trichrome stain X 5 ). (Reproduced by permission
from Tanagho EA, Smith DR, Guthrie TH: Pathophysiology of functional ureteral obstruction.
/ Urol 104: 73, 1970.)

brane,22'2’’ congenital structures, or de
ficient musculature.
Histologic studies of such a functionally
obstructive segment revealed a much
simpler etiology: these segments have an
abundance of circularly oriented fibres
(Fig. 11) (instead of the normal mixture
of fibres running in every direction), which
act as a sphincter and commonly involve
the juxtavesical ureter.26 Is this abnormal
muscular orientation caused by a lack of
ureteral stretching at this particular level
during embryonic life with persistence of
the embryonic circular orientation of
muscle fibres? It is an attractive hypothesis
that is hard to prove, but experimentally
we have been able to induce persistence of
the circular orientation in the fetal ureter,3
and the fact remains that this abnormal
muscular arrangement is the obstructive
Fig. 12.—(A) The course of a helical ureteral
muscle bundle. (B) Stretching every segment 1/2
times results in a tube IS times longer and wider.
(C) Stretching causes tortuosity because of the
relative fixation of the ureter at both ends.

«

A,
V

w

1
y-

January 1972

URETERAL D ILATATION

11

Fig. 13.—(A) Cross-section of an empty ureter. ( B) The same ureteral segment distended under
20 cm. fLO pressure. Note the available intraluminal capacity under such low pressure (Trichrome
stain X 5).

mechanism. Once the non-stenosed func
tionally obstructive segment is resected,
adequate ureteral drainage is restored.
The ureter in cases of functional obstruc
tion, unlike those of primary vesicoureteral
reflux, has normal musculature and re
sponds to this obstruction by dilatation
and also by muscular hypertrophy or over
activity. Results after repair of these cases,
especially with massive ureteral dilatation,
are better than for a similar degree of dila
tation in cases of primary reflux. This dif
ference is primarily owing to the status
of ureteral musculature before the obstruc
tive phenomenon affects the ureters.
D iscussion

Effect of Increased Intraluminal
Volumes
A single helical muscle bundle, like any
other smooth muscle bundle, will undergo

stretching and lengthening when subjected
to increased intraluminal volume (F ig. 12).
A longitudinal segment of the helix will
enlarge longitudinally, a transverse seg
ment transversely. This is what happens in
the ureter as a whole. Where the fibres
have a circular orientation ( as in the renal
pelvis), the increase will be more along a
transverse axis with minimal lengthening.
Where the fibres have a longitudinal
orientation, the increase will be along a
longitudinal axis with tremendous length
ening and minimal or no widening. As
seen histologically, the ureter has an equal
mixture o f fibres running in every direc
tion and will probably increase along every
axis equally.27 If it doubles its lumen, it
will probably also double its length. H ow 
ever, the intravesical ureter has a purely
longitudinal fibre orientation, which is
probably why it does not share in ureteral
dilatation and why a dilated ureter always
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Fig. 14.—(A) Intravenous pyelogram of a patient with right lower ureteral obstruction. (B)
Intravenous pyelogram three weeks after operation showing marked regression in ureteral dilatation.

tapers down to a fairly normal-sized intra
vesical ureter.
The first effect of increased intraluminal
volume, before it starts to stretch the heli
cal fibres, is to fill the available ureteral
lumen, which is appreciably wider than we
have been accustomed to visualizing by
means of intravenous pyelograms (Fig. 13).
Lately, by infusion pyelography, we have
been able to visualize the size of the intra
luminal diameter of the ureter before
pathologic dilatation. Until accumulating
urine has filled the reserve capacity of the
ureteral lumen, there is an increase only
in ureteral diameter with no increase in
length. After the reserve capacity has been
used up, dilatation and tortuosity of the
ureter occur as pathologic phenomena of
overstretching. The resultant length of the
chronically obstructed ureter can be twice
or three times normal with a similar degree
of dilatation. The ureter is relatively fixed
at both ends and any increase in its length
will lead to a tortuous course.

Reversibility
An acutely obstructed ureter can recover
once the obstructive mechanism is cor
rected (Fig. 14).28 However, a severe and
prolonged obstruction, especially if it is
associated with infection, could cause
serious ureteral damage and markedly
limit recovery even with the freest drain
age.
Another major factor limiting reversi
bility is the degree of ureteral muscular
development existing before the onset of
ureteral dilatation. Poorly muscularized
ureters, commonly encountered in severe
vesicoureteral reflux19 and probably in
some patients with prune-belly syndrome,
have a limited ability to recover. Such
ureters may fail to recover and continue to
dilate and decompensate even after correc
tion of reflux, probably because they can
not handle even normal resistance at the
site of reimplantation. Nothing short of the
direct free drainage of diversion would
help these patients. Even this may not lead
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to ureteral recovery, but it may stop
further dilatation. Ureteral muscular de
velopment and activity should always be
considered when choosing the best man
agement for each individual patient with
dilated ureters, especially massively de
compensated ureters.
Sum m ary
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The ureter has only one muscular coat
whose individual muscle bundles have an
irregular helical arrangement. Increased
intraluminal volumes stretch these muscle
bundles equally in every direction, leading
to dilatation and lengthening.
Several physiologic states lead to ureteral
dilatation: ( 1 ) increased urine volume
(diuresis); ( 2 ) increased normal resistance
at the ureterovesical junction (bladder
filling); and (3 ) muscular atony (preg
nancy and contraceptive pills). Pathologic
ureteral dilatation is due to: (1 ) mechani
cal obstruction (stones, tumours); (2 )
vesicoureteral reflux owing to the impact
of repeated overstretching, high pressures,
increased volumes, and congenital muscu
lar weakness; (3 ) infravesical obstruction
or neurogenic vesical dysfunction because
of trigonal hypertrophy aggravated by tri
gonal stretching due to variable residual
urine; ( 4 ) trigonal irritation and spasm;
and (5 ) functional ureteral obstruction due
to derangement in muscle fibre orientation,
commonly in the juxtavesical ureter.
The ureter has a remarkable capacity for
recovery unless its musculature is congeni
tally deficient or pathologically fibrosed.
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R esu m e
L ’uretere ne possede qu’une seule couche musculaire, dont les faisceaux individuels sont disposes
en helice irreguliere. L ’augmentation de volume
du calibre interieur etire ces faisceaux musculaires
egalement dans toutes les directions et aboutit a
la dilatation et a l’allongement.
Plusieurs facteurs physiologiques conduisent a
la dilatation des ureteres: ( 1 ) augmentation du
volume urinaire ( diurese); ( 2 ) augmentation de
la resistance normale de la jonction ureterovesicale (remplissage de la vessie) et ( 3 ) atonie
musculaire ( etat de grossesse et contraceptifs).
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La dilatation pathologique de l’uretere est causee
par: ( 1 ) une obstruction mccanique ( calculs,
tum eurs); ( 2 ) un reflux vesico-ureteral provoque
par l’impact (retirements excessifs et repetes, par
des pressions elevees, des volumes urinaires aug
m e n ts et par une faiblesse musculaire congenitale; ( 3 ) une obstruction infravesicale ou un
trouble fonctionnel de la vessie d’origine neuro
gene, par exemple par une hypertrophie du tri
gone aggravee par un etirement dudit trigone
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sous l’influence d’un residu urinaire variable; ( 4 )
une irritation et un spasme du trigone et (5 ) par
une obstruction fonctionnelle de l’uretere causee
par un derangement de l’orientation des fibres
musculaires, souvent au niveau de la portion
juxtavesicale de l’uretere.
L ’uretere a une capacite de recuperation remarquable, a moins que sa musculature ne soit
deficiente congenitalement ou soit le siege dune
fibrose pathologique.

INTIMAL DAMAGE AFTER FOGARTY CATHETERIZATION OF
CANINE FEMORAL A RTERIES0
J. F . A. VANCE, M .D .,f D. W. JIRSCH, M .D .,t
H. T. G. W ILLIAM S, M.D., Ch.B., F.R.C.S.fEng. & C ], F.A.C.S. and
C. M. COUVES, M.D., F.R .C .S.(Ed in. & C ), F.A.C.S., E dm on ton , Alta.

formalin. These arteries served as controls.
The excised segment began 2 cm. below
the arteriotomy and extended distally. On
the right side, a No. 5 Fogarty catheter
was passed distally in the femoral artery,
the balloon inflated to a volume of 1.5 c.c.,
and the catheter withdrawn. There were
five dogs in each of the three groups: those
in which the right femoral artery was
catheterized once; those in which the
artery was catheterized twice; and those in
M ethod
which the artery was catheterized three
Fifteen adult mongrel dogs, weighing times. After catheterization, a 5-cm. seg
15 to 32 kg., were used in this study. All ment of the right femoral artery was ex
animals were anesthetized with sodium cised and placed in 10% formalin. The
pentobarbital and underwent a left total catheter was introduced and withdrawn
pneumonectomy in association with an smoothly and, in each dog, if resistance
other project. Immediately after this pro was encountered, the balloon pressure was
cedure, both femoral arteries were exposed decreased. No catheter bulbs were rup
and controlled with angled DeBakey tured intra-arterially.
clamps proximally and umbilical tapes
Longitudinal and transverse sections of
distally. Transverse arteriotomy incisions
all arteries were stained with both hema
were made in both arteries. After arterio
toxylin and eosin and Weigert’s stain and
tomy, a 5-cm. segment of the left femoral
were examined histologically.
artery was excised and placed in 10%

D espite advances in techniques of peri
pheral embolectomy, reocclusion of embolectomized vessels remains a perplexing
problem. In an effort to understand further
the phenomenon of thrombotic reocclusion
following embolectomy, we attempted to
assess the arterial damage produced by
successive passages of the Fogarty embo
lectomy catheter.

* From the Surgical-Medical Research Institute,
The University of Alberta, Edmonton, Alta.
This work was supported in part by Medical Re
search Council of Canada Grant M A-2553.
tFellow , Medical Research Council of Canada.
Reprint address: Dr. D. W . Jirsch, SurgicalMedical Research Institute, The University of
Alberta, Edmonton, Alta.

O bsebvations

Control Arteries
These arteries showed a uniformly wellpreserved intima with only minor areas of
fragmentation (Fig. 1). These areas were
focal and superficial, and we noted no sub-
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Fig. 1.—Control artery. The intima appears to be intact (Weigert’ s stain, original
magnification X 100).
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intimal hemorrhage nor damage to the
muscle layers of the vessel wall. Most of
the changes noted appeared to be cutting
artefacts and were predominantly in folded
or cracked sections.

Arteries S ubjected to Fogarty
Catheterization
These vessels all contained areas of in
timal stripping of variable length. Patho
logical changes were more severe than
could be expected from cutting artefacts
and were also found in cleanly cut and
well-preserved specimens. Although the in
timal loss was more marked in arteries
subjected to two or three passages of the
catheter, the limited number of sections
did not justify further correlation. In a few
sections we noted a mild degree of subintimal disruption but no significant subintimal hemorrhage or damage to muscle
layers (Figs. 2-4).
D iscussion

The arteries studied were those of
healthy young dogs and they were not
damaged either by atherosclerosis or by
impaction of an embolus. In addition, they
were removed immediately after smooth

passage(s) of the Fogarty catheter, al
though we realized that arteries previously
damaged by disease or left in situ for
longer periods after catheterization might
show more marked pathological changes.
Other factors can augment intimal damage
during catheterization but we avoided
these during this study. Overinflation and
balloon rupture can obviously break inti
mal continuity but hypoinflation with pre
sentation of an irregular balloon surface to
the vessel wall may have a similar effect.
Catheter withdrawal should be smooth and
continuous since initial intimal damage will
probably extend with any irregular force.
Repetitive instrumentation may be simi
larly detrimental producing further intimal
stripping and more extensive subintimal
hemorrhage and damage to the muscle
layers.
Intimal denudation alone, as produced
by our routine introduction and withdrawal
of a properly inflated catheter, could initi
ate thrombosis in a normal or diseased
vessel. Local trauma to the vessel may
activate tissue thromboplastin at the flow
ing blood/arterial wall interface and, in
addition, may neutralize the normal nega
tive charge of the internal vessel wall. Sub
sequent aggregates of platelets, fibrin and

16

THE CANADIAN JOURNAL OF SURGERY

Vol. IS

V

-t

Fig. 2.—Artery after one passage of a No. 5 Fogarty catheter. The intima is frag
mented in several places (Weigert’s stain, original magnification X 100).

erythrocytes could alter the hemodynamics
of laminar flow and thereby induce further
thrombus formation leading eventually to
occlusion of the vessel. Postoperative anti
coagulation with heparin might prevent

certain of these effects but it is commonly
some hours before stable anticoagulation is
established clinically and, in any event,
extensive vascular damage may persist.
Our findings are somewhat at variance

A*

V

Fig. 3.—Artery after two passages of a No. 5 Fogarty catheter. A large area of intima
has been stripped off (Weigert’s stain, original magnification X 100).
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Fig. 4.—Artery after three passages of a No. 5 Fogarty catheter. Little intirna remains
in this illustration (Weigert’s stain, original magnification X 100).
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with those of Fogarty and Cranley1 who
stated that the catheter was so designed
that, within the bounds of surgical caution,
arterial perforation, plaque disruption, intimal dissection and arterial rupture are
avoided. The bursting point of the rubber
jacket was intentionally put far below the
point that would cause intimal damage.
However, in a later description of 128 embolectomies, Krause et al.2 described two
instances of gross intimal stripping, two of
plaque dissection and one of arterial per
foration.
We suggest that intimal damage may
be more common than previous reports
imply.11 The catheterized arteries all ap
peared grossly normal and yet all had some
degree of microscopic intimal loss.
C o n c lu sio n s

f
4

We conclude that Fogarty catheteriza
tion does cause immediate arterial wall
damage. The damage is predominantly
microscopic intimal loss, although subintimal disruption was occasionally seen as
well. We suspect that this damage may be
progressive with successive passages of the
catheter, but the number of arteries studied
does not warrant a definite conclusion in
this regard.

We postulate that the intimal loss ob
served in these arteries may play a role in
the vessel thrombosis and reocclusion that
occasionally follow peripheral embolectomy.
Referen ces
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R esu m e
Les auteurs ont etudie histologiquement, chez
15 chiens batards adultes, des segments des deux
arteres femorales. Ils ont excise, apres arteriotomie, des segments des arteres femorales gauches,
pour servir de temoins. Quant aux segments des
arteres femorales droites, ils n’ont ete excises
qu’apres un certain nombre de passages (un, deux
et trois) d’un catheter de Fogarty No 5. Au
point de vue histologique, les arteres-temoins
etaient nonnales. Par contre, certaines sections
des arteres catheterisees revelaient soit la frag
mentation, soit la perte de l’intima. L a fragmen
tation subintimale n’a ete notee qu’occasionnellement. L ’ampleur de la lesion de 1’intima etait
directement proportionnelle au nombre de pas
sages du catheter.
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ELEM EN TA L D IET IN THE MANAGEMENT OF THE INTESTINAL
LESIONS PRODUCED BY RADIATION IN THE MOUSE0
J. S. HUGON, M .D.t and G. BOUNOUS,
T h e lesions produced by x or y rays have

been intensively studied.1'5 The first tissues
to be damaged are the intestinal mucosa
and the hematopoietic system. Depending
on the dose, the dividing undifferentiated
cells of the intestinal crypt are arrested in
mitosis or killed and, eventually, these
cells are extruded into the lumen of the
intestine. These lesions produce a more or
less extensive desquamation of the intesti
nal epithelium and, subsequently, mal
absorption.
To prevent this radiation enteropathy,
several radioprotective drugs have been
used in animals. Nearly all of them are
toxic and can be lethal if administered for
several days.8 However, when injected a
few minutes before the irradiation, they
provide a high level of protection.7
Another way to manage the intestinal
lesion is to enhance the process of repair in
order to promote a faster renewal of ab
sorptive cells. It is for this purpose that we
have studied the effect of an elemental
diet. Previous experiments have shown the
value of this diet in protecting the intesti
nal epithelium in ischemic enteropathy8
and in 5-fluorouracil ( 5-FU ) injury.9’ 10
M a t e r ia l a n d M ethods

Swiss ICR male mice, 3 months old,
were used in all experiments. The effects
of y radiation on 30-day survival and the
morphology of the intestine were recorded
using different dietary regimens.
Diets
Three types of diet were used:10
The first (D iet A) was Purina chow.
"Supported by the National Defence Research
Board and the Medical Research Council of
Canada.
fAssociate Professor of Pathology, Centre Hospitalier Universitaire, University of Sherbrooke,
Sherbrooke, Que.
^Associate Professor of Surgery, Centre Hospi
taller Universitaire, University of Sherbrooke;
Research Associate, Medical Research Council of
Canada.

Sherbrooke, Que.

The second (Diet B ) was the test or
elemental diet and consisted of highly
hydrolyzed food. The composition of this
diet (Mead Johnson product 3200-A.S.)
was described in a previous publication.10
The third (Diet C) differed from Diet B
only in that the enzymatic casein hydro
lysate was replaced by an equal amount
of whole casein.
All these diets were administered ad
libitum in powder form from stainless steel
cups designed to reduce spillage. All ani
mals drank water ad libitum and were
housed on stainless grids to prevent
coprophagy. The diets were administered
for seven days before the irradiation and
continued until the death of the animals
or the end of the test period.
Irradiation
Mice were confined in a specially con
structed plastic circular holder divided into
15 compartments and were exposed from
a dorsoventral direction to a y-ray beam
from a cobalt-60 source at a dose rate of
100 R./min. Doses of 700, 900, 1000 and
1350 rads were used. All animals were
irradiated in the afternoon. The test diet
group was paired with its control group.
Mortality
The mortality was studied over a 30-day
period.
In the first experiment, 20 mice received
Diet A (Purina) and 20 received Diet B
(elemental). They were irradiated with
900 rads. In the second experiment, 30
mice received Diet C (whole casein) and
30 Diet B (elemental). They were irradi
ated with 900 rads. In the third experi
ment, 30 mice received Diet A (Purina)
and 30 Diet B (elemental). They were
irradiated with 1000 rads.
In each experiment, the test group was
irradiated at the same time as its own
paired control group. However, the three
experiments were made at different times;
for example, the first experiment was

January 1972

ELEMENTAL

DIET

carried out in the fall, while the second
was done in the winter.
The animals were weighed seven days
before irradiation, on the day of irradia
tion, and at 10 and 30 days thereafter.
TABLE I.— W e ig h t ( g .)

RADIATION

19

glutaraldehyde and embedded in Epon for
the electron microscopic study.
For statistical analysis of mortality rates,
we used a two tailed t test based on the
original number of mice, and the number

of M ic e B e f o r e a n d A f t e r 900 R ads y R a y s .
N u m b e r o f M ic e in B r a c k e t s

I

Diet C (30) (whole casein)
Diet B (30 (elemental)

AND

II

41.59 ± 3.71
40.14 ± 3.76

III

39.05 ± 2.99
40.85 ± 4.90

IV

34.15 ± 4.38
36.60 ± 4.06

32.93 ± 2.77*
38.68 ± 3 .99f

I = weight before the diet; II
= weight afterone week of diet
(day of
after 900 rads of y rays; IV = weight of survivors 30 days after irradiation.
*vs;

(10)
(19)

irradiation); III

fP < 0.001.

Histologic Study

of surviving and dead animals at 30 days.

Only the first part of the jejunum was
studied. In a first experiment, 30 mice re
ceived Diet C (whole casein) and 30 Diet
B (elemental). They were irradiated with
700 rads and sacrificed at one, two, three,
four, five and six days. In a second experi
ment, 10 mice received Diet A (Purina)
and 10 Diet B (elemental). They were
irradiated with 900 rads and sacrificed at
one and four days. In a third experiment,
10 mice received Diet A (Purina) and 10
Diet B (elemental). They were irradiated
with 1350 rads and sacrificed at three and
six days.
The jejunum was fixed by immersion in
alcoholic Bouin and processed to paraf
fin embedding. Hematoxylin-eosin and
periodic acid-Schiff staining were used.

Mitotic Index
In a first series of experiments, nine mice
received Diet C (w hole casein) and nine
Diet B (elemental). They were irradiated
with 700 rads and sacrificed at two, three
and four days after irradiation.
In a second series o f experiments, nine
mice received Diet C and nine Diet B.
They were irradiated with 1000 rads and
sacrificed at two, four and six days after
irradiation.
The mitotic index was evaluated on 2000
nuclei in the jejunal crypts of each animal.
The number of nuclei per crypt was also
measured.
R esults

Weight

Electron Microscopic Study

Table I shows the weight of the mice at
different time intervals in relation to
irradiation. The first group ate Diet C
(whole casein) and the second Diet B
(elemental); the difference in weight be-

In each of the preceding experiments,
blocks o f jejunal epithelium were im
mersed in 1% phosphate-buffered osmium
tetroxide or in 3% cacodylate-buffered
TABLE

II.—E f f e c t

of

D i e t o n R a d ia t io n D e a t h in M ic e

Cumulative mortality
(days)

Nc. of
mice

7

U

Diet A (Purina)
Diet B
(elemental 3200-A.S.)

900 rads
900 rads

20
20

4
0

12
7

16
11

17
11

85
55

Diet C (whole casein)
Diet B
(elemental 3200-A.S.)

900 rads
900 rads

30
30

3
6

18
11

20
11

20
11

0 5 .5J
33.38

1000 rads
1000 rads

30
30

4
5

29
29

30
30

30
30

Diet A (Purina)
Diet B (elemental)
|P < 0.02;

Jvs;

§P < 0.005.

SO

%
mortality at
SO days

21

'vs;

= weight 1

100
100

*
f
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Fig. 1.—Light microscopy, 700 rads, 24 hours,
Diet C. Clear vacuoles are observed at the tips
of the villi (arrow), above the nuclei (X 214).

tween the two groups was not significant
before irradiation. However, at the end of
the experiment, the weight of the survivors
taking the elemental diet (D iet B ) was
significantly higher (P < 0.001) than that
of the survivors eating Diet C (whole
casein). The two diets maintained body
weight before irradiation.

Fig. 3.—Light microscopy, 1350 rads, six days,
Diet A. The mucosal epithelium of the villi is still
irregular with some foamy cells. Two karyolytic
bodies are seen embedded in absorbing cells
(original magnification X 214).

Vol. 15

Fig. 2.—Light microscopy, 700 rads, 24 hours,
Diet B. No such clear areas are noted (X 214).

Mortality
Table II shows the mortality in the three
different experiments. The following con
clusions may be drawn.
In the first experiment (900 rads), the
mice taking the elemental diet (Diet B)
had a lower 30-day mortality rate than
controls taking Purina (Diet A ). In the
same experiment all the mice taking the

Fig. 4.—Light microscopy, 1350 rads, six days,
Diet B. The layer of mucosal cells is continuous
on the villi. The cells are tall and appear nonnal
(original magnification X 214).
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Fig. 5.—Light microscopy, 1350 rads, three
days, Diet A. Villi are extremely atrophic with
cuboidal cells. Crypts are irregular with several
nests of undifferentiated cells dispersed in the
lamina propria (original magnification X 214).

Fig. 6.—Light microscopy, 1350 rads, three
days, Diet B. Villi are atrophic. The crypt is taller
than in Fig. 5. Moreover, at the mouth of the
crypt, near normal absorbing cells begin to mi
grate on the villi (original magnification X 214).

elemental diet were alive at seven days
while four of the control group died.
In the second experiment (900 rads),
the mice eating the elemental diet again
had a lower 30-day mortality rate than the
group eating whole casein (Diet C ).
In the third experiment (1000 rads), the
two groups of mice ran the same course
with no survival after a 30-day period.

vacuoles were observed above the nuclei
in those on whole casein but they were
absent in those on the elemental diet.
Forty-eight hours
after irradiation,
mitosis was equal in the undifferentiated
cells of both groups.
After three days we could identify no
differences between the two groups be
cause the mucosal epithelium was normal.
900 r a d s—Twenty-four hours after ir
radiation, the same lesions were observed
in both groups, i.e. numerous karyolytic
bodies in the crypt cells with desquama
tion in the lumen of the crypts.
Four days after irradiation, the columnar
cells of the jejunal villi were taller in the
mice taking the elemental diet than in the
group eating Purina. Similarly the lesions
of the crypts had totally disappeared in the
group eating the elemental diet.

Light Microscopy (Figs. 1 to 6)
Jejunal morphology was studied on sec
tions stained with hematoxylin and eosin.
Doses of y rays were 700 rads, 900 rads
and 1350 rads.
700 racls.—'Twenty-four hours after ir
radiation, the lesions of the undilferentiated
cells of the crypts were similar in the two
groups of mice regardless of diet. How
ever, at the tip of the villi, large empty
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Fig. 7.—Electron microscopy, 900 rads, four days, Diet A, absorbing cells of the villus. The
microvilli are irregular, some are fused. Smooth endoplasmic reticulum is dilated. Numerous large
and small lipid vacuoles are seen (x 19,900).

Fig. 8.—Electron microscopy, 900 rads, four days, Diet B, absorbing cells of the villus. The
microvilli are regular. Mitochondria present numerous dense granules. No lipid droplets are observed
besides small aggregates in the Golgi cisternae. Large cytosomes are present in the supranuclear
region (x 7700).
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Fig. 9.—Electron microscopy, 900 rads, four days, Diet A, Golgi zone. Large vacuoles with
lipid droplets are seen. Lipid granules are present between the cells (arrow) (x 30,780).

1350 r a d s —In the two groups, the mor
tality was high and on the sixth day the
survivors appeared very ill.
Three days after irradiation, the villi
were atrophied in both groups and showed
small clear cells. However, more blunt villi
were still covered with a layer of flat cells
in the animals taking the elemental diet
than in the group eating Purina.
Six days after irradiation, in the sur
vivors, the mucosal epithelium was nearly
normal in the elemental diet group but
still flat and irregular in the Diet A group.
Electron M icroscopy (Figs. 7 to 10)
The lesions seen in the crypt cells of all
mice were similar to those already
described after x- or y-ray irradiation re
gardless of the diet taken.3’ 4 However, in
the villi of animals not taking the elemen
tal diet, the absorbing cells situated at the
apex of the villi showed numerous large
lipid vacuoles packed in the cytoplasm.
This finding, which was evident 24 hours
after 700 rads and four days after 900 rads,
is of considerable interest because these

mice had always fasted for 18 hours be
fore radiation. In the elemental diet ani
mals, very few small lipid granules were
occasionally seen in the same area.
Four days after 1350 rads of y rays,
there was severe atrophy of the columnar
cells of the mice eating the elemental diet.
Cuboidal cells with small microvilli and
numerous cytoplasmic vesicles covered the
villi. Mitochondria were vacuolated. In the
control animals, the lesions were more
severe and large sheets of epithelium had
disappeared. The remaining absorptive
cells were flat with small microvilli, large
dilatation of endoplasmic reticulum and
accumulation of lipids.
M itotic Index
Table III shows the number of mitoses
and number of nuclei per crypt in two
different series of experiments. In mice re
ceiving Diet B, the number of mitoses per
crypt is significantly higher (P < 0.0005)
on the third day after 700 rads and on the
fourth and sixth day after 1000 rads than
in controls receiving Diet C.
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Fig. 10.—Electron microscopy, 1350 rads, four days, Diet A, absorbing cells of the villi. Flat
elongated cells with irregular nuclei and condensed nucleoli are seen. The microvilli are atrophic. A
goblet cell with a few mucous granules can be seen. Lipid areas are dispersed in the cytoplasm (x
D is c u s s io n

This study indicates that ingestion of an
elemental diet benefits mice receiving y
radiation. This benefit is evident in the
histology of the intestinal mucosa regard
less of the radiation dose given and it is
crucial enough to improve survival of the
mice receiving 900 rads.
Examination of the histology of the
jejunal mucosa makes it possible to specu
late on the type of protection given by an
elemental diet as well as the possible
mechanism involved.
The early radiation lesions seen on the
in t h e

TABLE III.—E f f e c t

J e ju n u m

of

o f D ie t o n M it o sis an d o n N u m b e r o f N u c l e i p e r C r y p t
M ice A f t e r 7 - ray I r r a d ia t io n . T h r e e M ic e in E ach C a s e . 2000 N u c l e i p e r M o u se

2 days
D ie t C *

Mitosis per crypt 1000 rads
700 rads
Nuclei per crypt
♦Whole casein;

first day are most striking in the crypts
where mitotic figures were arrested or de
stroyed. This change was unaffected by the
diet at all levels of radiation. This finding
suggests that an elemental diet does not
protect the crypts against radiation injury.
However, the crypts recovered more
rapidly from this injury when the elemen
tal diet was taken.
We have confirmed that the more
mature cells seen on the villi also suffer,
as evidenced by the accumulation of lipids
and the presence of vacuoles appearing at
24 hours. This type of lesion, which, as ex4 days

3 days
D iet B t

D ie t C

D iet B

0.39 + 0.11 0.62 + 0.09
P < 0.05
0.99 + 0.35 0.77 ± 0.28 1.25 + 0.09 2.13 + 0.34
P < 0.15
P < 0.0005
1000 rads 26.33 + 0.9 28.32 + 1.5
P < 0.1
700 rads 26.90 ± 2.29 26.83 ± 3.56 46.36 ± 4.45 52.83 ± 2.40
P < 0.0025

f Elemental.

D ie t C

6 days
D ie t B

2.25 + 0.22 4.16 +
P < 0.0005
1.88 + 0.26 2.20 +
P < 0.1
71.6 + 5.8 79.5 ±
P < 0.012
64.31 ± 4.16 49.78 ±
P < 0.01

D iet C

D iet B

0.45 1.91 + 0.35 3.00 + 0.35
P < 0.0005
0.55
3.2 69.0 ± 8.46 79.83 ± 3.76
P < 0.02
13.99
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pected, is more severe as the radiation dose
increases, was definitely milder in the ele
mental-diet animals. Also, the beneficial
effect of the diet became increasingly
obvious with the passage of time after
injury.
We interpret these results to mean that
an elemental diet probably does not affect
the initial radiation damage but facilitates
the process of repair.
Sufficient data is available to suggest a
likely explanation for the mechanism of
action of the elemental diet. The utiliza
tion of carbohydrates and proteins from
the chyme by the intestinal mucosa nor
mally requires a terminal process of hydro
lysis, which occurs in the absorbing epi
thelium. This step is essential for proteins
which are found in the intestinal lumen
mostly in the form of peptones. We have
already shown that the intestinal lesion
produced by 5-FU is accompanied by an
apparently selective fall in peptidase ac
tivity in the absorbing cells.9 We have also
noted a great similarity between radiation
and 5-FU enteropathies. It is conceivable
that irradiation has a similar effect on these
intestinal enzymes, thereby hampering pro
tein utilization and cellular repair. This
would also explain the inability of the in
jured cells in our control animals to mobi
lize the absorbed fat and to transport it
into the lacteals. Indeed it is known that
intracellular protein synthesis is necessary
for chylomicron formation. It is obvious
that mice eating proteins in the form of
amino acids can dispense with the process
of cellular hydrolysis and can both absorb
and utilize these nutrients. Furthermore,
rats on an elemental diet show an apparent
drop in mucosal cellular peptidase activity.®
This decreased activity, however, may be
attributed to a selective decay of the en
zyme when the tissue is preserved frozen.
W e are investigating this possibility.
Our hypothesis concerning the mechan
ism of action of the elemental diet rests
to a large extent on the observation
that mice taking a diet which differs only
by the presence of the same proteins in a
non-hydrolyzed state (whole casein, Diet
C) do not show any significant improve
ment over control mice eating Purina chow
(D iet A ).
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The ingestion of amino acids may not
only facilitate the process of repair in the
intestinal mucosa but may also provide for
the synthesis of proteins that are essential
to the recovery of other tissues damaged
by radiation, such as the bone marrow and
liver. This could explain the improved
survival rates obtained with the elemental
diet at the 900-rad dose level.
The effect of radiation on intestinal en
zymes is known to some extent.11,12 Galjaard et al.13 and Spiro and Pearse14 have
shown that low doses of x rays (400 R )
do not modify the enzymatic content of the
villus mucosa in the first days following
irradiation. But with higher doses, which
cause considerable cell damage, significant
decrease of enzymatic activity including
peptidase has been reported.15
Table II shows that mice eating the ele
mental diet and receiving the same radia
tion dose in the first and second experi
ments had different 30-day mortality rates.
This can probably be explained by the fact
that the experiments were carried out at
different seasons of the year. In addition,
the mortality of the control group in each
experiment was similarly affected so that
the ratio of mortality between the paired
groups in each experiment was identical.
The effect of nutrition on the response to
radiation has been studied by several
authors.16 Protein depletion was shown to
increase the susceptibility to total body ir
radiation.17 Walburg, Mynatt and Robie,18
studying the mortality of irradiated germfree mice, observed that the animals sup
plemented with a synthetic diet formed by
pure amino acid, vitamins and salts pre
sented a slope of the mortality curve, an
increase of the LD-)0/ (30) and a decrease
of the weight loss after irradiation. On the
other hand, Smith and Tyree19 demonstrat
ed in irradiated rats that forced feeding by
stomach tube or by subcutaneous injection
is harmful after small dosages of irradia
tion.
Regarding the optimal protein require
ments in the face of severe injury, Markley, Smallman and Thornton,20 in a study
of burn mortality in mice, found that the
protein content of diet should be between
8% and 12%. This corresponds to the pro
tein content of our Diets B and C.
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While the intestinal radiation lesion is
similar in man and rodents, more work will
be required to determine to what extent
elemental diets will be applicable clinically
in humans subjected to abdominal irradia
tion.
Summary

An elemental diet (Mead Johnson 3200A.S.) containing amino acids instead of
proteins has been shown to improve sig
nificantly the 30-day survival in mice fol
lowing 900 rads of y rays.
The elemental diet also produced sig
nificant benefit in the intestinal mucosa.
The initial radiation damage in the intesti
nal crypts was unaffected by the dietary
regimen, but the elemental diet led to a
faster recovery from such lesions and the
mitotic index was higher in these animals.
In the absorbing cells of the villi, the ini
tial lesion was lessened by the elemental
diet and the repair process was greatly
facilitated.
Presumably, irradiation impairs the
ability of the intestinal mucosa to perform
terminal digestion of protein; hence inges
tion of amino acids is beneficial because
such terminal digestion is no longer neces
sary.
The authors wish to thank Dr. fi. J. Perey,
Surgeon-in-Chief, University of Sherbrooke, for
reviewing the manuscript and Dr. J. E. Knapp of
the Mead Johnson Company of Canada for tech
nical and scientific assistance. They are also
greatlv indebted to the Radiotherapy Department
of the University of Sherbrooke Medical Center
for its comprehensive help in the irradiation
process and to Mrs. E. Hugon-Renaud for her in
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R esume
Une diete elementaire (Mead Johnson 3200A.S.) dont toutes les proteines sont hydrolysees
sous forme d’acides amines, ameliore significativement la survie de souris irradiees par 900 rads de
rayons 7 . La reparation morphologique de la
muqueuse intestinale semble egalement facilitee.
Si les lesions immediates au niveau des cryptes ne
sont pas modifiees par le regime, il semble par
contre, que les cellules absorbantes des villosites
retrouvent plus rapidement leur integrite. De plus
la reprise mitotique est acceleree. L e fait que
1’hydrolyse des proteines alimentaires est probablement perturbee par l’irradiation, pourrait expliquer le role benefique d’une diete foumissant
directement des acides amines.
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B LO O D STR E A M IN F E C T IO N A SSO C IA TE D W IT H
PR O L O N G E D IN TR A V E N O U S TH E R A P Y 0
N. D. COLAPINTO, M .D., P. BEDARD, M .D. and B. S. GOLDM AN, M .D., F.R.C.S.[C],
Toronto, Ont.

I ntravenous infusions are an essential part
o f daily patient care. They are often em 
ployed for many days because o f illnesses
requiring prolonged fluid, electrolyte, anti
biotic or metabolic therapy. Multiple ven e
punctures are disturbing to the patient and
costly in time to hospital personnel. Thus,
plastic intravenous cannulas have been d e
veloped which have less tendency to allow
fluid to escape into the tissues or becom e
obstructed by thrombus. These cannulas
may then remain in situ and function for
a considerable time. Recently, numerous
sources o f hospital-acquired infections have
been recognized and documented. The
purpose o f this paper is to stress that the
com m on intravenous infusion should not be
considered casually; intravenous therapy,
and in particular the intravenous cannula,
may be the source o f a significant num ber
o f bloodstream infections.
Our interest was stimulated by tw o ep i
sodes o f septicemia occurring within a
single week.
C ase R eports
Case 1.—J.T. developed a severe unexplain
ed deep thrombophlebitis in the right lower
limb following vigorous exercise. She was
treated with bed rest and intravenous heparin,
given as two-hourly injections into a con
tinuous drip. Being an anxious young girl, she
nursed the intravenous carefully in order to
avoid a second venepuncture. After eight days
with the same plastic cannula in place, her
oral temperature inexplicably spiked to 105° F.
Blood cultures were taken and antibiotic
therapy was begun, after which her tempera
ture returned to normal. The next day her
temperature again rose dramatically to 107° F.
and she had shaking chills, cyanosis and an
apical rate of 180 beats per minute. Aside
from general supportive measures, significant
"From the Department of Surgery, University of
Toronto, and the Division of Cardiovascular
Surgery, Toronto General Hospital, Toronto, Ont.
Reprint address: Dr. B. S. Goldman, Cardiac
Unit, Toronto General Hospital, Toronto 101, Ont.

management included removal of the intra
venous cannula. Following this, her condition
improved and her temperature rapidly re
turned to normal. She had no further recur
rence and remained well ( vide infra).
Case 2.—J.G. developed deep thrombo
phlebitis six days after prosthetic replacement
of a diseased aortic valve. On the fourth day
of intravenous heparin therapy, his tempera
ture rose suddenly to 105° F. accompanied
by a single chill. Having been alerted to the
possibility of the intravenous tubing or infu
sion acting as a source of infection, the can
nula was promptly removed. His symptoms
rapidly subsided with no other treatment and
with no recurrence.
In both these patients no source o f en
dogenous infection was ever demonstrated.
In both instances, cultures taken from the
intravenous puncture site and the tip o f
the plastic cannula grew the identical
organism cultures from the bloodstream
(E . coli in the first, and P. aeruginosa in
the second case).
Having becom e aware o f this problem ,
w e were able to demonstrate that the intra
venous cannula was the source o f b lo o d 
stream infection in three other patients
during the next tw o months.
P ossible Sources of B loodstream
C ontamination D uring P rolonged
I ntravenous T herapy
( 1 ) The first obvious source is the
bottle; the solution m ay have been co n 
taminated during manufacture. A m ore
com m on source is the unfiltered vent in
serted into the bottle, w hich m ay allow
airborne contamination to be sucked in
with each drop o f fluid.
( 2 ) Other sources are related to p oor
nursing technique and casual handling.
Intravenous medications are often inserted
directly into the bottle or into the side-arm
of the plastic tubing. T o o often, n o anti
septic w ipe is used or the m edications are

THE CANADIAN JOURNAL OF SURGERY

28

injected before the antiseptic can take
effect.
(3) The volume-control and blood-filter
portions of the intravenous tubing become
an ideal culture medium soon after de
livery of blood transfusions. Frequently
this filter system containing clotted blood
is left in the intravenous line for a con
siderable period.
(4) The “piggy-back” intravenous is a
simple way to deliver two solutions through
a single route. It consists of the needle of
one intravenous line inserted into the sidearm of another. Unfortunately, this line is
often loosely attached with ordinary ad
hesive tape, permitting sufficient movement
of the needle to allow contamination. Simi
larly, the open-ended three-way stopcock,
inserted to allow flushing of venous and
arterial pressure lines or to inject medica
tions, often lies exposed to contaminants.
(5) The technique of inserting an intra
venous cannula probably contributes more
to the development of sepsis than those
factors already mentioned. A cursory wipe
of the skin with a mild antiseptic solution,
followed by the unsterile fingers feeling the
vein must certainly deliver skin bacteria to
the end of the cannula. There is, further
more, a variable degree of motion of the
plastic cannula at the puncture site, again
contaminating the intravenous portion.
D isc u ssio n

Infections acquired in hospital from the
use of various types of therapeutic equip
ment are serious and well-recognized prob
lems. Ventilatory apparatus, including
anesthetic machines, and indwelling drain
age systems have been particularly impli
cated. Intravenous therapy has also been
described as a source of bloodstream con
tamination, but it is used so commonly,
that few have heeded the warnings in the
literature.
One of the earliest descriptions of hospi
tal-acquired septicemia from indwelling
intravenous catheters was reported by
Neuhof and Seley1 in 1947. Hassall and
Rountree2 reported their experience with
staphylococcal septicemia from 1950 to
1957. In 50% of the 40 patients infected in
hospital, infection was believed to have
arisen from the intravenous cannula.
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Andriole et al.3 reviewed 21 cases of Can
dida endocarditis and noted that five of
these cases were attributed to the use of
prolonged intravenous therapy for bacterial
endocarditis. Smits and Freedman,4 in
1967, reported 98 cases of septicemia and,
of these, nine were traced directly to the
intravenous cannulas, all of which had
been in place for a period of 2% to seven
days. This study concluded that catheter
sepsis represented the single most impor
tant cause of staphylococcal septicemia
with a significant mortality rate. In 1969
Darrell and Garrod5 reported three cases
of septicemia developing from prolonged
intravenous therapy. Two were due to
Candida albicans and the third to Staphy
lococcus aureus; two of the infections were
fatal. Michaels and Ruebner6 in 1953
demonstrated organisms flourishing in the
intravenous bottle in two patients with
gram-negative septicemia.
Although these and other scattered re
ports of well-documented individual cases
have appeared in the literature over the
years, true awareness of the problem seems
only recently to have become apparent.
Collins et al.7 reported a prospective study
of 213 intravenous cannulas left in place
for longer than 24 hours. “Local” infection,
defined as a positive culture of the cannula
tip, was found in 35%. There was an
almost linear trend with the duration of
cannulation. Four cases of cannula septi
cemia occurred, two of which proved fatal.
Phlebitis occurred in 39% of the patients;
the frequency increased as the duration of
the cannula in situ increased. Surprisingly,
the presence of phlebitis did not have any
correlation with the development of sub
sequent septicemia.
Bentley and Lepper8 described a retro
spective study of 2556 intravenous units
which had been in place longer than 24
hours. The venous catheter was considered
the source of infection only if no other
potential source was present. In this study,
44 cases of septicemia occurred, and the
intravenous cannula was the commonest
source of infection (19 cases). The intra
venous units had been in place an average
of 5.2 days. Significantly, all septicemias
occurred with cannulas that had been in
place 60 hours or more.
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C o n c lu sio n s

Intravenous therapy, and in particular
the plastic intravenous cannula, may be a
source of bloodstream infection.
If the intravenous unit has been in place
less than 48 hours, septicemia probably
does not occur. All cannula-related septi
cemias thus far reported have occurred
after the intravenous had been in place a
minimum of 48 hours.
It is estimated that 20% of all hospitalacquired septicemias are related to the
intravenous unit itself. No infections have
been reported with the use of stainlesssteel needles. The exact mechanism of in
dwelling intravenous catheter sepsis is
unknown. It is probably related to the
technique of venepuncture, the amount of
injury to endothelium at the time of inser
tion, and continued movement of the
catheter.
Staphylococcus is the causative organism
with much greater frequency than is gen
erally seen in septicemias—about 70%
compared with the usual 15% to 20%.
Systemic antibiotics will not control such
infections, as long as the intravenous can
nula remains in situ.
Hospital procedures should insist on an
aseptic technique for venepuncture, with
local shave, adequate antiseptic prepara
tion and perhaps antibiotic creams. Plastic
cannulas should be used only when neces
sary, changing the cannula and/or the
intravenous tubing and volume control or
filter unit every 48 hours.
In all patients with unexplained septi
cemia, the intravenous cannula should be
suspected and promptly removed.
Summ ary

We have presented two patients with
hospital-acquired septicemia arising from
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infection at the site of intravenous cannulation. Possible sources of contamination
are noted for purposes of establishing
prophylaxis. The most important considera
tion appears to be aseptic insertion and
maintenance of the cannulas and frequent
replacement of the intravenous tubing. The
intravenous unit should be suspected as the
source of infection in all cases of un
explained hospital-acquired septicemia.
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R esu m e
j Les auteurs presentent deux malades souffrant
d’une septicemie contractee a l’hopital, l’infection
ayant pris naissance au siege de la ponction intraveineuse. Ils passent en revue les sources possibles
de contamination, en vue d’etablir des mesures
prophylactiques. Le point le plus important est
de respecter les conditions d’asepsie au moment
de la ponction, d’entretenir les aiguilles et de
remplacer souvent les tubes servant a la perfu
sion intraveineuse. L ’appareillage a intraveineuse
devrait etre soupgonne d’etre la source de Tinfection dans tous les cas de septicemie iatrogene.
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L E CANCER DE L ’CESOPHAGE: RESULTATS THERAPEUTIQUES
L. CONRAD PELLETIER, M.D., F.R.C.S.[C],8 JACQUES BRUNEAU, M.D., F.R.C.S.[C],t
JEAN-PAUL CHOLETTE, M.D., F.R.C.S.[C]f et JEAN-P. FAUTEUX, M.D., F.R.C.S.[C],t
Montreal, Que.

Depuis 1962, un nouveau programme
Malgre le developpement de nouvelles
techniques chirurgicales et de radiothe- therapeutique a ete mis a l’essai, base sur
rapie, le cancer de l’oesophage demeure les nouveaux moyens de radiotherapie et
Tune des lesions tumorales les plus diffi- l’utilisation de la transposition colique ou
ciles a traiter efficacement et son pronostic gastrique pour reconstruire la continuite
est encore generalement mauvais. Apres oesophago-gastrique.
resection de la tumeur, le taux de survie de
Le present travail porte sur la serie de
cinq ans varie de 6% a 16% .1-4 En 1963, malades traites depuis 1962, dans le but
Logan" a rapporte une serie personnelle de d’evaluer la valeur de la conduite thera
544 cas et revu Fexperience anterieure de peutique actuelle.
Ellis, Nakayama et Sweet. L’ensemble de
ces quatre series comprenait 1981 cas. Le
M ateriel C linique
taux de resection allait de 27% a 78% et
De 1962 a 1969, 75 nouveaux cas de
la survie de cinq ans, obtenu par la chirurcancer
de l’oesophage ont ete vus a l’Hotelgie, de 10% a 15%.
Dieu de Montreal et servent de base a
En 1962, les resultats du traitment du
cette etude retrospective (tableau I). Notre
cancer de l’oesophage a FHotel-Dieu de
Montreal furent releves.8 De 1949 a 1962,
TABLEAU I.— L o c a lisa tio n d e s L e s io n s ,
113 cas avaient ete diagnostiques. QuaS e x e e t A ge
rante-six malades avaient recu de la radio
Tiers
therapie seulement et 47 avaient subi un
Tiers inferienr
Tiers
traitement chirurgical, palliatif pour 27,
superieur moyen et cardia Total
curatif dans 20 cas. La seule technique
75
39
26
chirurgicale alors employee etait l’oeso- Nombre de cas 10
60
21
Hommes
7
38
phago-gastrectomie. Comparativement aux Femmes
9
1
5
3
63.5
64.9
58.8
70.1
malades non traites, la chirurgie palliative Age moyen
n’avait montre aucune amelioration de la
survie et la radiotherapie employee seule serie comporte sept fois plus d’hommes que
s’etait revelee a peine plus efficace. Les de femmes. Pour les tumeurs du tiers supeseules survies de plus d’un an avaient ete rieur de l’oesophage, cependant, ce rapport
obtenues avec la chirurgie curative. Vingt- n’est que de trois pour un. Les deux tiers
cinq pour cent des malades dont la lesion des malades etaient dans la cinqnieme et
avait pu etre enlevee en entier avaient la sixieme decades et Fage moyen au mo
survecu plus d’un an et la duree moyenne ment du diagnostic etait de 63.5 ans.
de la survie etait triplee comparativement
La ligne de conduite en ce qui a trait au
aux autres malades (de cinq a 15 mois). traitement des malades operables fut la
Cependant, la survie maximum fut de suivante: pour les tumeurs du tiers infequatre ans, dans un cas. Meme si la chirur rieur de l’cesophage ou du cardia, l’oesogie curatrice semblait donner les resultats phago-gastrectomie avec reanastomose diles plus favorables, l’absence de survivant recte fut pratiquee, sans radiotherapie;
a long terme indiquait la necessite de re pour les lesions situees au tiers superieur
viser le traitement de ces malades.
ou moyen, une derivation par transposition
colique ou gastrique etait faite en premier
lieu, suivie de radiotherapie au cobalt;
‘’Mayo Clinic, Rochester, Minn. 55901, U.S.A.
apres un delai de trois mois ou plus, l’oesoJDepartement de chirurgie, Hotel-Dieu de Mont
phagectomie etait envisagee, si la lesion
real, Montreal, Que.
avait montre un arret de sa progression
JChef du departement de chirurgie, Hotel-Dieu
avec la radiotherapie.
de Montreal.
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R e su ltats

C’est le tiers moyen de l’cesophage qui
est le plus souvent atteint, dans notre serie,
avec 39 cas, suivi du tiers inferieur et du
cardia avec 26 (tableau I). La maladie survient a un age un peu plus jeune au tiers
inferieur, alors que les malades atteints de
lesions du tiers superieur sont souvent ages
de plus de 70 ans (age moyen: 70.1 ans).
L’epithelioma epidermoide est de loin
le plus frequent a tous les niveaux et tota
lise plus des deux tiers des cas (tableau
II). L’adenocarcinome, rencontre a 10 ocTABLEAU I I . — T

y p e s H is t o l o c iq u e s e t
M eta sta ses

Tiers
Tiers
superieur moyen

Epidermoides
7
Ad6nocarcinomes 0
2
Indifferencies
Melanome
0
Inconnus
1
Presence de
0
m etastases
(60%)

30
1
2
i
5
16
(40%)

Tiers
inferieur
et cardia

Total

Hi
9
1
0
0
18
(70%)

53
10
5
1
G
40
(53%)

casions, origine presque toujours au cardia.
Nous n’avons observe qu’un seul cas d’origine oesophagienne, au tiers moyen. Cinq
autres tumeurs etaient de type indifferencie et chez six malades le diagnostic histologique n’a pas ete etabli. Nous avons eu
un cas de melanome du tiers moyen de
I’oesophage. Des metastases ganglionnaires
ou viscerales ont ete demontrees dans plus
de la moitie des cas. C’est avec les lesions
du tiers inferieur et du cardia qu’elles
etaient les plus frequentes (70%). Seuls
les ganglions etaient envahis chez 29
malades, sept autres avaient en plus des
lesions metastatiques hepatiques ou pulmonaires et dans trois cas les metastases
etaient generalisees.
TABLEAU I I I . — T r a i t e m e n t
Nombre de

cos
Aucun traitem ent
R adiotherapie seule
Chirurgie seule
Chirurgie et radiotherapie

18 (24% )
21 (28%)
19 (25%)
17 (2.3%)

A cause de leur maladie trop avancee,
17 patients n’ont rear aucun traitement
autre que des dilatations cesophagiennes ou
une gastrostomie dans quelques cas. Un

31

autre malade a refuse tout traitement
(tableau III). La radiotherapie fut em
ployee dans 21 autres cas juges inoperables, en association parfois a des dilata
tions ou une gastrostomie. Parmi ces deux
groupes de malades, l’inoperabilite fut
constatee a l’exploration chirurgicale chez
12. Trente-six malades (48% ) ont ete
soumis a un traitement chirurgical; la
radiotherapie y fut associee pour 17 d’entre
eux.
L’cesophago-gastrectomie avec anasto
mose oesophago-gastrique fut employee
chez 18 malades, porteurs de lesions du
tiers inferieur ou du cardia, a 1’exception de
deux cas ou la tumeur siegeait au tiers
moyen (tableau IV). La radiotherapie postTABLEA U IV .— T r a i t e m e n t C h ir u r g ic a l

(Esophago-gastrectomie
CEsophagectomie et
derivation p a r tube
gastrique
colique
D erivation seule par tube
gastrique
colique

Nombre
de cas

Presence de
metastases
ganglionnaires

18*

12

71
2
5
lit
2
9

2
3

*Radi'jt-h6rapie p is to p e ra to ire : un cas; chez un
malade, deuxieme resection p o u r reeidive e t recon
struction avec un tube colique gauche.
fT ous ont eu de la radiotherapie associee, sauf un
cas.

operatoire fut associee a une seule reprise.
Un de ces malades a du etre reopere deux
ans plus tard pour une reeidive. Une nouvelle resection fut faite et un tube colique
employe pour la reconstruction.
Pour 16 cas de tumeur du tiers moyen,
le programme chirurgical en deux temps
associee a la radiotherapie fut entrepris.
Dans un premier temps, nous avons procede a la derivation oesophagienne, a l’aide
d’un tube colique en position retro-sternale
a 12 reprises, d’un tube gastrique pour
quatre autres. Tous ces malades ont ete
ensuite soumis a la radiotherapie. Apres un
delai de trois mois ou plus, I’cesophagectomie fut tentee chez sept d’entre eux et
la resection fut possible dans cinq cas
(31%). Les autres malades etaient decedes
ou devenus inoperables.
Chez un malade, une tumeur du tiers
inferieur fut resequee et la reconstruction
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TA BLEAU

V.— M obbiditb e t M o rtalite O pera to ires

(Esophago-gastredomies
Nombre de cas
Mortality opdratoire
Complications operatoires
fistules cervicales
fistules abdominales
fistule thoracique
stenose du tube
occlusion intestinale
6ventration
ischemie du tube
Duree moyenne
d’hospitalisation (jours)

Transpositions coliques
ou gaslriques

7
1
1

19
2
11

18
2
2

6
3

1

3
2
1
1

1
25

oesophagienne faite avec un tube colique
en un seul temps. Une autre malade fut
soumise a Fexerese dune tumeur du tiers
superieur et la continuity oesophagienne fut
retablie par anastomose directe. Deux ans
plus tard, on a du proceder a une deriva
tion par tube colique a cause d une stenose
oesophagienne, sans recidive de la maladie.
En tout, 11 patients n’ont pu benificier
que d’une derivation oesophagienne suivie
de radiotherapie, alors que pour sept autres
la resection oesophagienne fut possible.
II y avait de l’envahissement ganglionnaire dans la piece chirurgicale de 17 de
ces 36 malades. C’est dans les lesions du
tiers inferieur et du cardia que l’incidence
d’envahissement etait la plus forte (deux
tiers des cas).
La mortalite operatoire fut de 11% pour
Foesophago-gastreotomie, 10% pour la
transposition colique et nous avons eu un
deces parmi sept cesophagectomies (tableau
V). Les complications operatoires furent
particulierement nombreuses avec les trans
positions coliques et gastriques. Cinquantesept pour cent de ces cas ont presente une
ou plusieurs complications, la plus frequente etant la fistule cervicale ou abdominale. La fermeture spontanee de ces
fistules fut cependant la regie. Une stenose
du tube est survenue a trois reprises, toujours sur un tube gastrique, dont Fun a
du etre revise. Un tube colique gauche s’est
infarci en cours d’intervention et on a du
proceder a la transposition d’un nouveau
tube a l’aide du colon droit. La morbidite
operatoire pour l’oesophago-gastrectomie et
l’oesophagectomie fut nettement plus faible:
12% des malades seulement ont presente
une complication. La duree moyenne de
l’hospitalisation des malades soumis a une

(Esophagectomies
(deuxibme temps)

66
oesophago-gastrectomie fut presque trois
fois plus courte.
Des 18 malades non traites, un seul a
survecu un an et la survie moyenne fut de
quatre mois (tableau VI). La radiotherapie
employee seule a 21 reprises a donne deux
survies d’un an (10%) et une survie de
deux ans (5%), mais la survie moyenne du
groupe ne fut que tres peu affectee (5.5
mois). La meme survie fut obtenue lorsque la radiotherapie fut associee a une
derivation oesophagienne, sans que le
traitement soit complete par Fexerese de la
tumeur. Aucun de ces neuf malades n’a
vecu un an apres l’intervention. L’un d’eux
est decede d’une hemorragie oesophagienne
secondaire a une cirrhose, au cours de la
radiotherapie. A l’examen histologique de
l’oesophage, on n’a retrouve aucune trace
de cancer residuel. Tous les autres malades
de ces trois groupes sont decedes, de leur
maladie.
TA BLEAU V I.— S urvies

Traitement
Aucun
Radiotherapie
Derivation et
radiotherapie
CEsophagogastrectomie
Derivation,
resection et
radiotherapie

Survie
Nombre moyenne* Survies de
de cas (mois) 1 an 2 ans 5 ans
18
21

4
5.5

1
2

0
1

0
0

9

5 .5

0

0

0

16

10.5

3

1

1

13

i

1

2

6

*Patients dec6des seulement.

Les seules survies a long terme furent
obtenues lorsque la resection oesophagienne
a pu etre realisee. De ces 22 malades, on
compte trois survies de plus de cinq ans
(14%), deux de deux ans et quatre autres
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d’un an pour un total de 23% et 41% ceci, on ajoute 1’age avance de la plupart
respectivement. Parmi les 16 malades sou- de ces malades et les sequelles d’ethylisme
mis a une cesophago-gastrectomie, la piece chronique chez plusieurs, on a le contexte
chirurgicale montrait une atteinte gang- clinique suffisant pour expliquer des resullionnaire chez 10. Quatorze sont mainte- tats decevants.
nant decedes apres une survie moyenne de
De toute evidence, le premier pas vers
10.5 mois. Trois des cinq survivants plus une amelioration du taux de survie est un
d’un an apres la chirurgie ne presentaient diagnostic plus precoce. Tout patient d’age
pas de metastases ganglionnaires. Le seul a presenter une tumeur maligne de l’oesomalade qui a regu de la radiotherapie post- phage devrait etre completement investigue
operatoire a survecu un an. Deux patients au moindre soupgon: examen radiologique
sont encore vivants, 19 mois et cinq ans et endoscopique de l’oesophage, accomapres l’intervention. Des six malades sou- pagne d’une biopsie s’il y a lieu.
mis d’abord a une derivation cesophagienne
A cote du grand nombre de malades
suivie de radiotherapie et qui ont survecu d’emblee inoperables, la chirurgie d’exea la resection oesophagienne faite dans un rese, lorsqu’elle est possible, ne donne en
deuxieme temps, trois sont encore vivants, core que des resultats limites pour ce qui
deux, cinq et sept ans apres leur operation. est des survies a long terme. La radio
La survie moyenne des trois autres fut de therapie employee comme seul traitement,
13 mois, dont une survie de plus d’un an. meme si elle prolonge la survie de quelques
Aucun des malades vivants n’avait de meta mois, n’a en general apporte que de rares
stases ganglionnaires lors de la chirurgie.
survies de cinq ans. En 1965, Parker
De l’ensemble des malades soumis a la et Gregorie12 rapportaient une survie
resection oesophagienne en association a la moyenne de 5.2 mois apres radiotherapie,
radiotherapie, cinq etaient libres de metas- sans survie de cinq ans. Moseley9 obtenait
tase et d’extension extra-oesophagienne a une survie de 12 ans, mais la moyenne
l’operation: 80% ont survecu plus dun an pour 26 cas etait de six mois. La radio
(quatre patients), 60% plus de deux ans therapie nous a donne des resultats du
(trois patients) et 40% sont vivants apres meme ordre, sans survie au-dela de deux
une evolution de plus de cinq ans (deux ans. Par contre, dans une serie de 1870 cas
patients).
presentee par Pearson en 1969,13 les resul
tats de la radiotherapie etaient superieurs
a ceux de la chirurgie, avec des survies de
D iscussion
cinq ans de 20% et 11% respectivement.
Des 75 malades souffrant d’un cancer
En 1964, Nakayama14 publiait son expe
oesophagien que nous avons vus au cours
des sept dernieres annees, quatre pour cent rience avec la radiotherapie pre-operatoire
seulement ont vecu plus de cinq ans apres associee a la chirurgie. Ce traitement lui
que le diagnostic fut pose. Selon Naka- avait permis d’atteindre une survie de trois
yama en 1967,7 on ne retrouvait alors dans ans de 44.4% comparativement a 6.8%
la litterature que 301 cas ayant survecu avec la radiotherapie et 21.7% avec la
cinq ans. La principale cause de cette mor chirurgie seule. Chez sept malades, libres
tality elevee est le retard que met la ma- d’atteinte ganglionnaire et soumis au traite
ladie a se manifester cliniquement. Le ment combine, la survie etait de 100%.
diagnostic est alors souvent pose lorsque Selon lui, l’irradiation pre-operatoire de
la lesion a deja depasse tout espoir d’un 2000 k 3000 rads avait permis un meilleur
traitement curatif. La resection ne fut pos taux de resection en diminuant le volume
sible que pour un tiers de nos malades. Le de la tumeur et reduit la dissemination pertaux de resection generalement rapporte operatoire des cellules malignes. Ces pre
varie de 30% a 40%.'■ 3-8-11 De plus, miers resultats encourageants ont entraine
meme la ou la resection est possible, des l’adoption de ce programme therapeutique
metastases ganglionnaires sont tres souvent par plusieurs autres depuis lors.11- 1519 Une
retrouvees a l’examen de la piece chirurgi amelioration de la survie a long terme a
cale et demontrent que la maladie est plus ete constatee.18' 19 Goodner16 a note un
avancee qu’on l’avait d’abord cru. Si, a meilleur taux de resection et, dans sept cas,
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la disparition de la tumeur cesophagienne plusieurs que cette technique est taxee de
complications frequentes et nombreuses.20-23
apres radiotherapie.
La valeur palliative de la derivation
Depuis 1962, nous avons aussi adopte
ce traitement combine pour les lesions des cesophagienne apparait done tres discutiers superieur et moyen. Chez cinq ma- table. Bien que certains auteurs recomlades ainsi traites et libres de metastases, mandent Futilisation de la transposition
nous avons obtenu deux survies de plus de colique a titre palliatif,24- 25 nous ne
cinq ans et un troisieme patient est encore croyons pas que les resultats obtenus dans
vivant apres une evolution de plus de deux la plupart des series et dans la notre justians. Malgre le petit nombre de cas, ces fient cette attitude. Selon Duvoisin, Ellis et
resultats sont favorables, puisqu’ils repre- Payne,26 le tube de Celestin permet une
sentent presque les seules survies a long palliation tres satisfaisante, avec peu de
terme que nous avons pu obtenir dans le complications, tout en evitant au malade
une intervention majeure. Guernsey, Knudtraitement de cette maladie.
sen
et Mark27 recommandent une laparaPour les lesions du tiers inferieur et du
tomie
exploratrice et la biopsie des gang
cardia, l’accessibilite de la lesion et la re
construction simultanee plus facile nous lions coeliaques pour aider a preciser l’indiont fait opter pour l’exerese chirurgicale cation operatoire. En presence d’envahisseimmediate, sans avoir recours a la radio ment ganglionnaire, ils suggerent l’abstentherapie pre-operatoire. Meme si la survie tion de toute chirurgie ulterieure. Nakayamoyenne fut ainsi prolongee de deux fois, ma, Orihata et Yamaguchi,7 emploient la
comparativement aux malades non traites meme procedure comme premier pas theraou a ceux qui n’ont regu que la radiothe peutique et y associent une gastrostomie. Le
rapie, nous n’avons obtenu qu’une seule malade regoit ensuite une dose concentree
survie de cinq ans parmi 16 malades. Si la de radiotherapie et Foesophagectomie, si
resection est le plus souvent possible a ce elle est possible, est faite une semaine plus
niveau, des metastases ganglionnaires sont tard. Un tube externe sert alors de deriva
tres frequemment presentes au moment de tion temporaire et le remplacement oesol’intervention (10 de 16 cas). Nous croyons phagien est pratique apres une evolution
toutefois l’exerese chirurgicale justifiee de six a 12 mois, permettant d’evaluer le
dans ces cas, vu la faible morbidite de pronostic du malade. Avec ce programme
l’oesophago-gastrectomie et la prolongation therapeutique, la mortalite operatoire fut
certaine de la survie. L’utilisation de la abaissee a 2.5%, le taux de resection ameradiotherapie post-operatoire est suscep liore et la survie de cinq ans de 37.5%,
tible d’ameliorer ces resultats et devrait comparativement a 19.1% avec la chirur
gie seule.
etre consideree dans tous les cas.
Plusieurs techniques chirurgicales peuLe probleme des lesions oesophagiennes
situees a un niveau plus eleve est bien vent etre employees pour la reconstruction
different. Les metastases ganglionnaires cesophago-gastrique. Belsey28 suggere l’emsont moins frequentes parmi les cas juges ploi de l’oesophago-gastrostomie pour les
operables (cinq de 19), mais le taux de re lesions malignes, tandis que Nakayama,
section est de beaucoup inferieur et n’atteint Orihata et Yamaguchi,7 utilisent le tube
pas 50% de ces cas. La plupart des gastrique ante-thoracique. Staley et Scan
malades decedent au cours de la radio lon,29 discutant des diverses techniques de
therapie, apres avoir subi une derivation remplacement, favorisent le tube colique.
oesophagienne. En plus de la morbidite C’est cette derniere qui est actuellement la
tres elevee qui accompagne la transposi plus employee20, 21>24’ 25’ 30 et que nous
tion colique ou gastrique, celle-ci n’ame- avons aussi adoptee, avec des resultats
liore aucunement la survie du malade si fonctionnels satisfaisants. Plus important
une resection cesophagienne ne peut etre encore que la technique a utiliser, Fanafaite. Meme si la transposition colique tomie et Fintegrite vasculaires du segment
donne de bons resultats fonctionnels a long a transposer doivent etre inspectees attenterme, surtout lorsqu’utilisee pour des tivement de fagon a s’assurer a Favance
lesions benignes, c est aussi Fexperience de d’une irrigation sanguine adequate.
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LE CANCER DE L ’CESOPHAGE

C onclusion

II ne fait aucun doute que la radiotherapie associee a la chirurgie a ameliore le
pronostic des malades atteints de cancer
de l’oesophage, lorsque la lesion peut etre
resequee et qu’i] n’y a pas d’atteinte ganglionnaire. Son utilisation etendue aux
lesions du tiers inferieur peut laisser
esperer la aussi de meilleurs resultats. Par
ailleurs, un diagnostic plus precoce s’impose, si on veut parvenir a un taux de
resection superieur et diminuer l’incidence
des metastases ganglionnaires. Pour le
malade inoperable, il faut envisager une
palliation qui permettra une alimentation
adequate, tout en ne comportant qu’une
faible morbidite, vu la courte duree de la
survie. La derivation oesophagienne par
transposition colique ou gastrique ne prolonge aucunement la survie et, a cause de
ses complications trop nombreuses, ne peut
etre consideree comme une methode pal
liative satisfaisante. La prothese de Celestin, par contre, offre l’avantage d une mor
bidite moindre et semble donner de bons
resultats. La radiotherapie peut generalement offrir quelques mois de vie de plus a
ces malades. L’exploration abdominale et
la biopsie des ganglions coeliaques est un
autre rnoyen recommande pour preciser
l’indication operatoire et le pronostic du
malade, avant d’entreprendre une chirurgie
extensive, et elle devrait etre envisagee
pour les lesions des tiers moyen et supe
rieur de 1’oesophage.
R esume

Nous avons analyse les resultats therapeutiques chez 75 nouveaux cas de cancer
de l’oesophage vus a l’Hotel-Dieu de Mont
real, de 1962 a 1969. Cinquante-deux pour
cent des malades n’ont regu aucun traitement ou seulement de la radiotherapie. Les
survies moyennes furent respectivement de
quatre et 5.5 mois, sans survie de cinq ans.
Quarante-huit pour cent ont subi un traitement chirurgical et la radiotherapie y fut
associee chez pres de la moitie. La deriva
tion oesophagienne palliative n’a pas prolonge la survie des patients, alors que la
resection oesophagienne a permis d’obtenir
une survie moyenne plus de deux fois plus
longue que celle des autres groupes de
malades et a donne les seules survies de
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cinq ans de toute la serie. Des cinq ma
lades, libres de metastases, qui ont regu de
la radiotherapie et subi une derivation
oesophagienne, puis une cesophagectomie,
quatre ont survecu un an et deux sont
vivants apres une evolution de plus de cinq
ans. Le diagnostic precoce est un element
essentiel au pronostic de ces patients et
Fexploration abdominale peut permettre un
choix plus judicieux des candidats a un
traitement chirurgical. La derivation oeso
phagienne par transposition colique comporte un taux eleve de complications et, de
ce fait, ne s’avere pas une methode pallia
tive recommandable.
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Summary
The results of treatment of 75 new patients
with esophageal cancer seen at the Hotel-Dieu
Hospital, Montreal, between 1962 and 1969, are
presented. Thirty-nine (52%) patients received no
treatment, or radiotherapy only. The average
survival time was four and 5.5 months respec
tively with no five-year survival. Thirty-six (48%)
patients were treated surgically and almost half
of these received radiotherapy. Palliative eso
phageal replacement did not increase the survival
time; with esophageal resection (three five-year
survivors) survival was more than twice as long
as that observed among the other groups of pa
tients. In five patients, free of metastasis, who
were treated with radiotherapy and esophageal
replacement, followed by esophagectomy, four
survived one year and two are still alive more
than five years after operation. The authors stress
the importance of an early diagnosis; abdominal
exploration may allow a better choice of patients
to be submitted to further operative treatment.
Esophageal replacement by colon interposition is
attended by too many complications to be recom
mended as a standard palliative procedure.
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ACID-BASE CHANGES IN PATIENTS WITH INTRACTABLE PAIN
AND MALIGNANCY*
R. J. EVANS, M.R.C.S.[Eng.], C.R.C.S.[C],t Toronto, Out.

pain is a subjective phe
nomenon associated with a great variety of
organic and psychiatric states. At the Irene
Eleanor Smythe Pain Clinic in Toronto,
80% of patients referred to us have intract
able pain associated with advanced malig
nancy. These clinics, which have been held
regularly each week at the Toronto
General Hospital, Princess Margaret Hospi
tal and Queen Elizabeth Hospital since
1966, were established to study the causes
and management of intractable pain in the
expectation that treatment might be much
improved by a systematic and careful
study and evaluation. It was recognized
that any individual doctor or specialty
group saw only a few patients with in
tractable pain and that each tended to
apply particular techniques to the prob
lem. The Clinic was regarded as a mechan
ism to bring together a sufficient number
of patients, focus on their problems, and
study these problems in depth. Many pa
tients obtain relief of pain using orthodox
treatment, including analgesics—combined
with tranquilizers, steroids, radiotherapy,
chemotherapy, neurosurgical procedures,
and local nerve blocks. Most patients
with advanced malignancy do not present
with intractable pain, in spite of clinical
and radiologic evidence of disseminated
malignancy, and it is often difficult to
understand why one group should have
pain and the other not. Furthermore,
we do not understand how traditional
forms of therapy relieve symptoms or even
the mechanism of action of analgesics. The
purpose of this report is to record our ob
servations of acid-base changes associated
with varying degrees of pain associated
with malignancy.
In 1968 I made the chance observation
that people with intractable pain associI ntractable

0From the Departments of Surgery and Anes
thesia, University of Toronto, Toronto General
Hospital and The Princess Margaret Hospital,
Toronto, Ont.
fDirector of the Irene Eleanor Smythe Pain
Clinic; Research Associate, Department of Sur
gery, University of Toronto.

ated with advanced malignancy had
carbon-dioxide combining powers (C 02
cp.) in the upper range of normal, and
very often above normal, but when the
pain was relieved, by whatever technique,
the C02 cp. returned to the middle and
often the lower range of normal. At that
time a retrospective study of 175 such pa
tients at the Irene Eleanor Smythe Pain
Clinic showed an apparent linear relation
ship between the C 0 2 cp. and subjective
severity of the pain. On the strength of
this, a prospective study was set up to
determine the acid-base balance in 91 pa
tients with malignancy and pain, by esti
mating the arterial pH and blood gases.
M ethod of Study

Patients are referred to the Pain Clinic
for many reasons, including opinions on
the etiology, severity, disability caused by
the pain, observation of results of treat
ment, and for recommendations regarding
management of pain. The pain is clinically
assessed by participating physicians, in
cluding radiotherapists, anesthetists, mem
bers of all the surgical subspecialties, in
ternists and general practitioners.
The severity of pain is recorded in the
patient’s own words and, if the patient can
not describe the severity of his pain, an
objective assessment is made, based upon
the following criteria: mild pain—that
which allows a patient to participate in
normal social and occupational activities;
mild to moderate—pain that usually allows
normal social and occupational activities,
but intermittently keeps the patient at
home; moderate—that which keeps the pa
tient at home, unable to participate in
social and occupational activities; moderate
to severe—pain that keeps the patient at
home, requiring periods of rest; severe—
that which confines the patient to bed for
the greater part of the day, but allows
toilet privileges; very severe—pain that
confines the patient to bed at all times,
and precludes any movement; intractablepain that has been present for more than
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one month without remission, in spite of
treatment.
Patients were screened clinically by
taking detailed histories, and radiologically, for pulmonary, renal and metabolic
abnormalities that might materially alter
the acid-base status. No drugs were
allowed for at least four hours before the
investigation, and the patient rested for at
least 20 minutes before the blood sample
was drawn.
The severity of pain was subjectively
assessed, and simultaneously femoral arte
rial blood was sampled anaerobically,
using heparinized, standard, sterile, plastic
syringes and disposable needles. Samples
were immersed in ice and transported to
the laboratory for study within one-half
hour. The pH and blood gases were esti
mated under routine laboratory conditions,
using the radiometer method at Toronto
General Hospital and the Instrumentation
Laboratory technique at the Princess Mar
garet Hospital. Using the hemoglobin, arterial pH, and carbon-dioxide tension (P C 02),
the total carbon dioxide (TCCL), and the
base excess or deficit ( B E ) were calcu
lated, using a Sigaard-Andersen nomo
gram.1 At the same time, a blood sample
was taken for hemoglobin and serum elec
trolytes, including serum calcium estima
tion.
At the initial assessment of the 91 pa
tients, 21 had no pain and 70 had varying
degrees of pain. We saw many more pa
tients with severe and very severe pain,
but excluded them from our study, because
of other metabolic disturbances associated
with advanced disease, e.g. uremia, drain
ing fistulas, vomiting, or diarrhea. Of these
91 patients, 10 obtained remission of their
pain with conventional forms of treatment,
10 continued to have pain in spite of treatTABLE I. — I n it ia l pH

Pain severity
No pain
Mild and mild-moderate
Moderate and moderatesevere
Severe and very severe
*P < 0 .0 1 ;

|P < 0 .0 5 ;
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ment, and seven patients had increasingly
severe pain.
We did not take further arterial samples
from the remaining 64 patients, for various
reasons, e.g. medication having been taken
within four hours of consultation, the ad
ministration of blood transfusions or intra
venous therapy, the inadvisability of arte
rial punctures, the patient coincidentally
consuming antacids, the onset of hyper
calcemia, renal failure, vomiting because
of protracted constipation induced by
drugs, or simply inability to attend the
outpatient department because of disability
fo r

91 P a t ie n t s E x p e r ie n c in g

A/f

SD

TCO>
M*

SD

BE
M*

SD

21
33

7.400 ± .053
7.455 ± .043

37.5 ± 5.1
3 7 .2 ± 4 .5

24.4 ± 4 .3
2 6 .8 db 2 .2

— 1.4 ± 3 .0
2 .4 ± 1.8

30
7

7.460 ± .046
7.490 ± .049

40.7 ± 5 .5
3 8 .8 ± 5 .9

2 9 .6 ± 3 .2
30.1 ± 5.1

4 .7 ± 2 .8
5 .7 ± 4 .2

M = mean;

t

V.S.

Fig. 1.—Calculated base excess or deficit from
the first sample of arterial blood taken from 91
patients with varying degrees of pain.
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TA BL E I I — C h a n g es

in

A cid - B a s e S t a t u s A ss o c ia t e d W it h C h a n g es

in

P ain S e v e r i t y

pH

Pt'O,

TCOj

BE*

Conventional treatment:
Decreased pain— 10
patients

Before
After

7 .466
7.443

39.8
37.3

29.4
2 6 .5

4 .8
1 .5

Increased pain— 7
patients

Before
After

7.424
7.479

40.3
39.3

2 7 .3
3 0 .0

1 .9
4 .3

Supplementary acetazolamide with decreased
pain— 10 patients

Before

7.462

40.9

2 8 .8

4 .8

After

7.414

34.3

2 3 .2

— 2 .0

*P < 0.01.

or the distance involved. These patients
were subsequently excluded from further
research investigation.
R esu lts

mox), and all had a decrease in the
severity of pain. Fig. 2d and Table II show
the concomitant reduction in BE, and the
pattern of change also corresponds with
the relationship shown in Fig. 2a.

Arterial Blood Values

Mean values for the initial estimated pH
and blood gases in the 91 patients are
shown in Table I, and a scatter plot of the
absolute base excess or deficit values in
Fig. 1. Both indicate that the measured
(pH and P C 0 2) and calculated ( T C 0 2
and B E ) values increase progressively with
the increase in pain.
Analysis of variance showed that, for all
variables, real differences exist among the
mean values for the various pain cate
gories. The F ratios for the comparison of
the differences among the means were
largest for TCO , (12.03) and BE (25.30),
indicating that these calculated values dif
ferentiated more clearly between the pain
categories than the measured quantities,
and suggesting that differentiation was
similar for these variables, e.g. base excess
of + 5 .7 indicates acid-base status more
clearly than knowing the pH is 7.49 and
P C 0 2 38.8.
Table II shows changes in BE in those
patients whose pain was relieved with the
use of conventional forms of therapy. The
reduction in severity of pain was generally
accompanied by a reduction in BE. Fig. 2b
shows the data for base excess in seven
patients who had increasing pain in spite
of large frequent doses of morphine, and
each of these had a progressive increase in
the base excess (Table II, Fig. 2c), cor
responding consistently with the relation
ship shown in Fig 2a.
The 10 patients who continued to have
pain after conventional therapy were each
given supplementary acetazolamide (Dia-

D isc u ssio n

Ninety-one patients in this study had
varying degrees of metabolic alkalosis pro
portional to the severity of the pain. Pa
tients with advanced malignancy, who did
not have any pain, did not have acid-base
changes. When the patients who originally
had pain were relieved of it, the metabolic
alkalosis was relieved. The addition of
acetazolamide to the treatment of those
who continued to complain of pain ame
liorated the symptom. Thus, the relief of
metabolic alkalosis might be of consider
able importance in the management of in
tractable pain. The precise physiologic
significance of the alkalosis associated with
pain is not immediately apparent, but ap
pears to warrant further investigation.
Twenty per cent of patients with ad
vanced malignancy have metabolic alka
losis,2 but to date no one has correlated
acid-base balance with the degree of pain.
However, several workers have reported
the relationship between elevated P C 0 2
levels and head pains at high altitude.8
Metabolic alkalosis occurs in patients
who consume large quantities of bicarbo
nate, and those who have renal disease and
are dehydrated. The symptoms—mild
gastric complaints ( a distaste for food,
especially milk, intermittent nausea, vomit
ing and occasional abdominal pain) and
mood changes, including introspection,
irritability, and nervousness—may appear
in a few days, but commonly take a num
ber of weeks to develop.4
As the alkalosis becomes more severe.
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Mean B E

on 91 patients

Reduction in pain + B E (10 patients)
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-2

Vol. 15

Reduction in pain+ B E (I0 patients)
using supplementary Acetazolamide

-

O
-4 -

-6

-

x
-

First value c
Last value r,

X

11?

_ l _______ I_______ I_______ I_______ I_______I_______ I______

NIL MILD MrM. MOD. M.-S. SEV. V.S.

NIL MILD M^M. MOD. MrS. SEV. V.S.

Severity of pain
Fig. 2.—Patterns of calculated base values in relation to subjective severity of pain.

the patient may complain of headaches,
dizziness and lightheadedness. Neuro
muscular disturbances attributed to the
reduction of the ionized calcium may
produce myalgia, muscle spasms and, oc
casionally, tetany. Other signs that may
accompany progressive alkalosis include
low-grade fever, tachycardia, slow respira
tions, a flushed face, hyperesthesia and
hyper-reflexia. If untreated, metabolic alka
losis causes progressive weakness and

prostration, and eventually coma and death
due to the alleged nephrotoxic effect of
prolonged metabolic alkalosis.4 Patients
with intractable pain associated with
malignancy have many of these signs and
symptoms.
Ayers and Grace5 recently described in
tractable cardiac arrhythmias associated
with alkalemia, and Agostoni, Podda and
Signoroni6 pointed to the possible signifi
cance of alkalosis in stress. Adler, Roy and
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Reiman7 have reported that all degrees of
extracellular alkalosis produce alkalinization of cells, despite compensatory changes
in PC02 and extracellular bicarbonate con
centration, but acidification appears to
have no discernible effect on cell pH until
the PC02 rises above 70 mm. Hg, or inter
stitial fluid bicarbonate falls below 7
mEq./l. In acute pain, hyperventilation is
common, whereas in intractable pain, in
our experience, hyperventilation is rare.
Voluntary hyperventilation produces a
gross increase in blood pH within a few
minutes and reduces the plasma bicarbo
nate.8 Ayers and Grace5 coined the term
“inappropriate pulmonary ventilation in
the critically ill” to emphasize that either
hypoventilation or hyperventilation may
interfere with physiologic processes, and to
remind clinicians to treat the underlying
cause rather than continue to use in
appropriate drugs. According to Severinghaus et al.,8 the blood-cerebrospinal fluid
(CSF) barrier responds to the initial
hyperventilation alkalosis of acclimatiza
tion to altitude by actively reducing the
CSF-bicarbonate ion, and Giacobini9 has
reported that glia, like choroid plexus, is
rich in carbonic anhydrase. These facts led
us to ask what changes chronic metabolic
alkalosis associated with intractable pain
might induce in neurocellular integrity,
enzymatic function and ion exchanges.
According to Shenkin,10 patients with
organic pain have an abnormal diurnal
variation of plasma cortisol, and he sug
gested that the pituitary adrenocortical
secretion might respond differently under
the primitive stimulus of somatic pain.
Stanbury and Thomson11 described a regu
lar diurnal urinary excretion pattern in
healthy adults, in which the bicarbonate
excretion in the evening and when asleep
is lower than that on waking and in the
early part of the day. In our patients we
found a persistent paradoxical acid urine,
and the acid-base disturbances we observed
suggest that we might be able to correlate
the more severe nocturnal pain with fluc
tuations in bicarbonate levels.
In World War II, Beecher12’ 13 reported
that many extensively injured men did not
experience severe pain, and offered several
explanations for this phenomenon. Clou
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tier, Lowery and Carey14 emphasized that
humans with hemorrhagic traumatic shock
suffer a wide spectrum of acid-basc distur
bances and showed that some degree of
metabolic acidosis is common but that, in
many, the acid-base balance may be nor
mal, or “even alkalotic”. Unfortunately,
Beecher did not know the acid-base status
in his patients who did not have pain and
were not in clinical shock. These observa
tions raise the question: does the metabolic
acidosis accompanying hemorrhagic shock
induce some degree of analgesia?
In 1948, at a symposium on the treat
ment of painful disorders of skeletal
muscle,15 when asked why she included
ammonium chloride in the list of anal
gesics, Dr. Janet Travell answered: “In the
occasional case, dramatic relief of pain is
secured by the oral administration of am
monium chloride, 0.5 to 1.0 g., three times
a day. The mechanism is unknown, but it
might depend on the production of a
diuresis and withdrawal of fluid from the
muscles.” Aspirin compounds and opiates,
probably the most widely used analgesics,
induce acidosis, alter the mood and relieve
pain for varying intervals, yet in a minority
of patients in normal therapeutic dosages,
they may be completely ineffectual.
In a few patients with pain refractory
to conventional therapy, we attempted to
reduce the base excess with acetazolamide
(Diarnox), and thus reduce analgesic re
quirements and more effectively control
the pain. In these patients the improve
ment does not occur dramatically, and pain
continues on movement of areas where
there is gross skeletal destruction, e.g.
pathologic fractures, but the pain at rest
is more easily controlled. With acetazola
mide, improvement takes 48 to 72 hours
and is associated with a marked reduction
in base excess. We are now conducting a
prospective study to define more accurately
the part played by acid-base balance in the
intractable painful states associated with
advanced malignancy.
Other groups of patients with intractable
pain problems are also being studied in the
same way at the Clinic, but the numbers
are too small in each sub-group to validate
any report of the findings to date, How
ever, in patients where no organic cause
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for pain can be determined, e.g. psychiatric
patients, acid-base balance is normal, but
in patients with pain and skeletal dis
orders, e.g. rheumatoid arthritis, a similar
metabolic alkalosis has been demonstrated.
These observations will be reported later.
Su m m a r y

Intractable pain presents one of the most
difficult and challenging problems in as
sessment and management. The physio
logic changes accompanying intractable
pain, and mechanism of action of con
ventional therapy are not well understood.
A study of 91 selected patients with in
tractable pain and advanced malignancy
showed that they have a metabolic alka
losis proportional to the subjective severity
of their pain. This alkalosis is corrected
when the pain is relieved with conven
tional treatment. When the pain continues
unrelieved, alkalosis persists and may
worsen. Treatment of the underlying meta
bolic alkalosis appears to alleviate the in
tractable nature of the pain.
These observations suggest that: intract
able pain and pain of increasing severity
is associated with a base excess; data on
acid-base balance may give a reliable indi
cation of the degree of the patient’s pain
and may explain the absence of pain in
severe hemorrhagic shock; the relationship
between acid-base balance and pain may
shed light on the action of analgesics and
the mechanisms of intractability; treatment
of the underlying alkalosis may aid in the
conventional management of pain.
This study was sponsored by the Irene Eleanor
Smythe Pain Research Fund, University of
Toronto. The author wishes to thank Mr. Conn
Smvthe, all participating physicians and ancillary
staff at The Princess Margaret Hospital, Toronto
General Hospital and Queen Elizabeth Hospital,
and Professor W. Reid, Department of Biometrics,
University of Toronto, for helping with the
statistical evaluation; also Mrs. R. Topp, for her
invaluable secretarial assistance.
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R esum e
Une douleur rebelle est un des problemes les
plus difficiles a evaluer et a traiter. On ne comprend pas bien les modifications physiologiques
qui accompagnent cette douleur rebelle, pas plus
que le mode d’action des traitements mis en
oeuvre pour la contrer.
Ayant choisi 91 malades souffrant de tumeur
maligne et de douleur opiniatre, les auteurs ont
constate qu’ils presentaient une alcalose metabolique proportionelle a Tacuite subjective de leur
douleur. Cette alcalose est corrigee une fois que
la douleur est soulagee par les analgesiques classiques. Si la douleur persiste, sans soulagement
aucun, l’alcalose persiste egalement et peut meme
s’aggraver. Le traitement de Talcalose metabolique
sous-jacente permet d’attenuer la nature rebelle
de la douleur.
Ces observations permettent de crone que: une
douleur rebelle ou une douleur dont Tacuite augmente s’accompagne d’un exces de base; des renseignements sur l’equilibre ^acide-base peuvent
constituer une indication precieuse sur le degre
de la douleur chez le malade et peuvent expliquer
l’absence de douleur dans le choc hemorrhagique
severe; la relation existant entre l’equilibre aciclobasique et la douleur peut jeter quelque lumiere
sur l’action des analgesiques et sur les mecanismes
qui interviennent dans la douleur opiniatre; traiter
Talcalose profonde peut faciliter le traitement de
la douleur par les analgesiques courants.
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S IG M O ID O R E C T A L IN T U S S U S C E P T IO N :
AN U N U SU A L R E C T A L M A SS A S S O C IA T E D W IT H
H Y P O K A L E M IC M E T A B O L IC A L K A L O SIS
ROBERT C. MOFFAT, M.D., F.R.C.S.fC]0 and MAURICE DANIEL, M.D.,+ Trail, B.C.

Sigmoidorectal intussusception is an un
usual condition which presents as an an
terior rectal mass and simulates a polypoid
lesion of the rectum. The following pre
sentation was associated with hypokalemic
metabolic alkalosis and, clinically, sug
gested a villous adenoma.
C ase R eport
Mrs. A.F., a 57-year-old white woman, was
admitted to the Hotel Dieu of St. Joseph
Hospital, Windsor, Ontario, on June 30, 1968.
For approximately 10 days before admission
she had profuse mucous diarrhea that occa
sionally contained gross blood. She denied
any previous difficulties with her bowel move
ments; they had always been regular and she
had had no previous episodes of diarrhea or
constipation. The family history, personal and
functional inquiry were non-contributory.
She was seen in the emergency room be
cause of her abdominal distension.
She was a well-developed, thin, white
woman who had lost 4 lbs. over the past three
months. Her blood pressure was 140/80 mm.
Hg and her pulse was 88/min. Her admission
temperature was 98° F. Her abdomen was
distended and somewhat tympanitic; bowel
sounds were normal. No abdominal masses
were palpable and there was no evident
tenderness or guarding. On rectal examination,
she had moderate external hemorrhoids and a
small perianal lipoma. Approximately two
inches above the anal verge was a large, soft,
irregular lesion obstructing the lumen and in
volving the anterior rectal wall. The clinical
impression was that of a villous adenoma
and/or a carcinoma of the rectum.
Initial laboratory studies included: hemo
globin 13.8 g./lOO ml.; leukocyte count 20,000/c.mm. with 80% neutrophils, 10% lympho
cytes and 3% monocytes; reticulocyte count
1.7%; prothrombin time 14.5 seconds; Westergren sedimentation rate 34 mm. in one hour;
alkaline phosphatase 30 King-Armstrong units;
serum
glutamic oxaloacetic transaminase
(SGOT) 26 units/ml.; lactic acid dehydro
genase (LDH) 310 units/ml.; indirect bilirubin
“The C. S. Williams Clinic, Trail, B.C.
113774 St. Gregory Road, Windsor, Ont.

0.3 mg./100 ml.; direct bilirubin 0.5 mg./100
ml.; serum sodium 130 mEq./l.; serum potas
sium 2.5 mEq./l.; serum globulin 2.0 g./lOO
ml.; blood urea nitrogen (BUN) 8 mg./100
ml.; and fasting blood sugar 136 mg./100 ml.
Urinalysis was negative for sugar, acetone and
albumin. Stool specimens on three occasions
were 4 + for occult blood.
The radiograph of the chest was normal.
Flat and upright films of the abdomen sug
gested that there was an obstructing lesion in
the region of the distal sigmoid colon. Electro
cardiogram demonstrated non-specific ST-segment changes.
On July 1, 1968 a sigmoidoscopic examina
tion showed a large edematous friable lesion
just above the anal verge. Several biopsies
revealed only non-specifically inflamed rectal
mucosa with no evidence of malignancy. Up
until this time the patient continued to have
profuse mucous diarrhea. Repeat films of the
abdomen revealed some distended small-bowel
loops and further distension of the large
bowel. Over the next four days her tempera
ture remained within normal limits; her hypo
kalemic metabolic alkalosis continued. Serum
sodium levels ranged between 133 and 135
mEq./l., and serum potassium levels ranged
between 1.9 and 2.9 mEq./l. During this time
the patient was receiving a minimum of 80
mEq. of potassium intravenously on a daily
basis.
On July 6, seven days after admission, the
patient’s temperature spiked to 102° F. On
this date she had a serum sodium of 135
mEq./l., a serum potassium of 2 .5 mEq./l.,
and a chloride of 98 mEq./l. On the follow
ing day a rectal and sigmoidoscopic examina
tion under general anesthesia showed a large
sausage-shaped lesion in the anterior rectal
area which projected into the lumen of the
rectal ampulla. For the first time, we recog
nized that this mass might represent a sig
moidorectal intussusception. Although the
sausage-shaped mass was polypoid, the ex
amining finger could be passed several centi
metres into it through a doughnut-like depres
sion in its centre. Through a lower midline
incision, approximately 400 to 500 ml. of seropurulent fluid was drained from the abdomen.
This was cultured but no growth was sub
sequently obtained. Exploration of the abdo
men was negative except that six to eight
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inches of sigmoid colon had intussuscepted
into the rectum. This was reduced with con
siderable difficulty. On reduction we saw that
the tip of the colon, which had been the apex
of the intussusception, had become necrotic
and had perforated at its centre. The involved
sigmoid colon was resected and the proximal
end brought out as an end-colostomy in the
left lower quadrant, and the distal end was
brought out as a mucus fistula. The patient
tolerated this procedure quite well.
Her postoperative course was uneventful
and approximately 2 V2 weeks later her colos
tomy was closed under general anesthesia. At
this time, her serum sodium level was 133
mEq./l., serum potassium level 3.0 mEq./l.,
serum chloride level 93 mEq./l. and her
plasma pH was 7.44. She was discharged on
July 31 and has remained free of symptoms
since.
D iscussion

In sigmoidorectal intussusception the
distal sigmoid and upper rectum prolapse
into the rectal ampulla. This may be inter
mittent or, as in this patient, may stimulate
a polypoid lesion of the rectum. According
to Goligher,1 this type of intussusception
differs from other types because it rarely
strangulates or completely obstructs the
bowel. He also stated that this type usually
reduces itself spontaneously. Our experi
ence with the patient described here con
tradicts this; she had frank perforation
with a seropurulent peritonitis.
Most case reports2,8 indicate that this
type of intussusception is usually caused
by malignant tumours. Upon pathological
examination of the resected colon, we
found a small benign polyp approximately
1.5 cm. in diameter and 4 cm. from one
end. The intussusception could have
started at this polyp. During the examina
tion of the resected specimen, the polyp
was nowhere near the apex of the intus
susception or its leading edge.
Intussusception such as this could be
considered a form of rectal prolapse and
consequently have the same type of patho
genesis. W e believe that most rectal pro
lapses are actually types of intussusception,
as recent cineradiographic studies4 have
demonstrated. Most of these intussuscep
tions begin in the rectosigmoid area, per
haps as a redundant sigmoid loop or an
abnormally long mesosigmoid.
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Profuse mucous diarrhea and blood
stained rectal discharge are the most com
mon symptoms in sigmoidorectal intus
susception and also in villous adenomas.
These patients may also have constipation
and a dragging sensation in the pelvis.
The telltale finding was an anterior,
sausage-shaped, polypoid mass with a
doughnut-like depression in its centre.
Certain large villous adenomas of the
sigmoid colon and rectum produce pro
found fluid and electrolyte depletion. The
syndrome was first described by McKittrick
and Wheelock5 in 1954. These tumours are
also associated with profuse mucoid
diarrhea. As is sometimes the case in pa
tients with villous adenomas, this patient
had a hypokalemic metabolic alkalosis,
presumably as a result of the profuse
mucous diarrhea. The colonic mucosa
secretes potassium even under normal cir
cumstances and mucus contains a con
siderable amount of potassium ion.
Sigmoidorectal intussusception should be
treated by an anterior resection of the
colon. However, because of the colonic
perforation and leakage, we elected to per
form an end-colostomy, resect the involved
segment, and create a distal mucus fistula.
C onclusion

An unusual case of sigmoidorectal intus
susception has been presented. Clinically,
the profuse mucous diarrhea, in associa
tion with the rectal mass and hypokalemic
metabolic alkalosis, suggested a villous
adenoma of the rectum. The pathogenesis
of this type of intussusception is thought
to be the same as rectal prolapse. Sig
moidorectal intussusception should be con
sidered in the differential diagnosis of
rectal masses.
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R esume
Les auteurs presentent un cas exceptionnel d’invagination sigmoidorectale. Au point de vue
clinique, la diarrhee muqueuse abondante, associee a la presence de la masse rectale et a
l’alcalose metabolique hypokaliemique laissait sup-
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poser qu’on avait affaire a un adenome villeux du
rectum. On estime que la pathogenie de ce type
d’mvagination est la meme que celle du prolapsus
rectal. Dans tout diagnostic differentiel de masses
rectales, il faut envisager la possibility d’une in
vagination sigmoidorectale.

BREAST CARCINOMA 30 YEARS A FT ER THOROTRAST
MAMMOGRAPHY*
M. Y. AHMED, M.D.t and II. D. ST E E L E , M,D.,$ Kingston, Ont.

T he development of cancer in a breast
previously exposed to ionizing radiation is
well recognized. Such cases have been re
ported in atomic bomb survivors1 and in
women who have had multiple fluoroscopic
examinations to control pneumothoraces
for pulmonary tuberculosis.2' 3 A rare ex
ample of radiation-induced cancer is that
which follows the use of Thorotrast, a col
loidal solution of thorium dioxide used to
visualize ducts and enclosed spaces. The
small particle size of this medium is ideal
for such work, but there is a radiation
hazard because the thorium radiation con
sists of 90% alpha, 9% beta and 1%
gamma rays. Since its first use by Hicken4
to diagnose breast lesions, two cases of
primary breast carcinoma have been re
ported following its use, and a third case
is reported here.
C ase Report
A 60-year-old woman was admitted to
Kingston General Hospital on November 27,
1969, with a one-month history of soreness
and puckering of the skin of left breast. Many
years before she had had an occasional bloody
discharge from both nipples during each of
three pregnancies. During her second preg"From the Department of Pathology, Kingston
General Hospital, and Queen’s University, Kings
ton, Ont.
tResident in Pathology, Kingston General Hospital.
^Associate Professor of Pathology, Queen’s Uni
versity; Research Associate, Ontario Cancer Treat
ment and Research Foundation.

Fig. 1.—Mammogram of the right breast show
ing density due to Thorotrast.

nancy in 1939, both breasts were investigated
by Thorotrast mammography at another hos
pital, but no significant abnormality was
found. In 1942, a lump developed in her left
breast and was removed in three pieces. These
contained a number of small hard masse.1
which were granular and yellow on the cu;
surface. There was no evidence of neoplasm
and the diagnosis was foreign-body granuloma
with necrosis.
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No additional lumps were noted in her
breasts until just before the present admission.
At this time, the right breast was normal but
the left breast contained a non-tender 2 x 2 cm. hard mass just lateral to the nipple. A
slightly puckered scar, the site of the previous
biopsy, was present over it.
Bilateral mammography showed a localized
collection of contrast medium centrally in the
right breast (Fig. 1). There was a diffuse dis
persal of contrast medium in the left breast
with two areas of concentration, one on the
medial and one on the lateral side (Fig. 2).

Fig. 3.—Roentgenogram of the left axillary area
showing multiple densities thought to be due to
Thorotrast in the lymph nodes.
greyish-yellow with white material scattered
irregularly in the central portion (Fig. 4). On
microscopic examination, the mass was largely
fibrous with irregularly sized and placed col
lections of refractile granular material inter
preted as Thorotrast. Adenocarcinoma was
present, especially about the periphery of the
mass (Fig. 5), but also in some areas within
it (Fig. 6). In addition, some of the small
ducts were lined by cells with atypical nuclei,

Fig. 2.—Mammogram of the left breast showing
two main areas of concentration of Thorotrast,
and also a diffuse dispersal throughout the tissue.
Both of these areas had extensive fibrotic
changes which the radiologist related to the
presence of the contrast medium. Lymph
nodes in the left axilla had densities suggest
ing Thorotrast (Fig. 3). Radiologic examina
tion showed no evidence of this agent in the
spleen or liver.
A left breast biopsy was done on December
1, 1969, and a modified Halsted radical
mastectomy followed the frozen-section diag
nosis of adenocarcinoma. A hard 3 x 3 x 1.5cm. mass, found just lateral to the nipple, was
gritty on sectioning and the cut surface was
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Fig. 4.—Cut section of the tumour of the left
breast, showing Thorotrast as white material scat
tered irregularly in the central portion of the
specimen.
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suggesting at least a premalignant state. A few
foci had plate-like refractile crystals with
multinucleated foreign-body cells about them
(Fig. 7). This material and the reaction to it
was unlike the Thorotrast granules. Auto
radiographs showed tracks characteristic of
alpha particles (Fig. 8). The axillary lymph
nodes had Thorotrast in and adjacent to them
(Fig. 9), but no tumour was found.
The remaining breast was removed several
weeks later and it had areas of fibrosis con
taining granular material compatible with

Fig. 5.—Photomicrograph of adenocarcinoma
extending out into fatty connective tissue from
the reactive fibrosis that contains the Thorotrast
(hematoxylin-phloxine-saffron stain X 312).

Fig. 7.—Photomicrograph o f a fibrous area of
left breast as seen under partially polarized light.
The Thorotrast shows as granular material (larger
arrow) and the unidentified refractile material is
white ( smaller arrow) ( hematoxylin-phloxinesaffron stain, original magnification X 500).

Thorotrast but no tumour. The specimen was
examined for gamma radiation but the amount
was too slight to be measurable.
D iscussion

Radt5 first described the use o f T h oro
trast to visualize the liver and spleen in
1929. A fe w years later, Selbie6 reported
that Thorotrast produced tumours in aniFig. 6.—Photomicrograph o f invasive adeno
carcinoma extending across the field adjacent to
Thorotrast (arrow) and in its reactive fibrosis
( hematoxylin-phloxine-saffron stain, original mag
nification X 86).
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Fig. 9.—

Fig. 8.—

Photomicrograph of an autoradiographic
preparation of tumour tissue showing the charac
teristic heavy straight lines produced by alpha
particles from the Thorotrast (dark granular
clumps). The beaded pattern reflects abundant
ionization with many silver grains at each point
(X 500).

Photomicrograph of left axillary node
showing Thorotrast material (black) within the
lymph node and also in the adjacent fatty tissue
(original magnification X 50).

exposed to the medium, including renal
pelvis, maxillary sinus, lacrimal duct, ovary
and breast. Tumours have developed in
sites distant from that under investigation,
sites such as the liver, lymph nodes and
mals. In 1937, an editorial in the Journal marrow, presumably because the agent was
of the Am erican M edical Association7 transported to these sites where it was col
warned its readers of the potential hazards lected and stored. Some tissues directly
of the diagnostic use of thorium dioxide, exposed, such as meninges, brain, spinal
saying that it could produce necrosis and cord and related tissues have not devel
malignant change in tissues with which it oped tumours, possibly because of local
remained in contact. In 1938, Romano and resistance or, more likely, because the
McFetridge8 described foreign-body reac Thorotrast was not retained at these sites.
Breast cancer following the investigation
tion to this substance in both humans and
experimental animals and concluded that of a breast lesion by Thorotrast was first
diagnostically this method did not contri described in a man by Austoni11 in 1950.
Dahlgren10 and Baserga, Yokoo and Henebute enough to warrant the risk.
In 1947, MacMahon, Murphy and Bates9 gar12 quoted this case in their reviews
first reported a sarcoma of the liver in a of Thorotrast tumours, but Brody and
patient who had previously received Cullen13 did not. Brody and Cullen stated
Thorotrast. Since then, over 60 tumours that they had found no report of a malig
thought to be caused by Thorotrast have nant tumour following the use of Thoro
been described. Dahlgren10 reviewed most trast for mammography and then described
of these in 1961 and, since then, over 30 such a case, but cautiously stated that
more of these tumours have been reported. there was no proof of causal relationship.
Intervals between the use of Thorotrast
Most of the tumours have been in the liver
and biliary tract but also in other sites and the diagnosis of subsequent tumour
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are reported as 19.4 ± 4.0 years for liver
carcinoma, 12.6 ± 7.4 years for liver sar
coma and 14.6 ± 4 . 3 years for extravascular sites of injection.12 The intervals in the
cases mentioned above were 12 and 17
years, which would fall within the last
range quoted; the case in this report, 30
years later, is one of the longest intervals
reported.
Although surgeons in the 1930s thought
that Thorotrast was a suitable and easy
medium to use, the filling of a closed-end
fine duct system, such as in the breast,
must have produced problems. The pro
cedure was safe if the thorium dioxide
could be completely removed, but if a duct
ruptured the Thorotrast gained access to
the connective tissue and remained there,
producing fibrosis and a potential neo
plastic change. Patients who have had such
examinations are now passing from the
latent period to that of clinical manifesta
tion and should be closely watched. Many
such patients may no longer be under
medical attention; if so, what steps should
be taken to find and have them periodically
examined?
Summary

A 60-year-old woman, who had had bi
lateral mammography with Thorotrast 30
years before, was found to have an adeno
carcinoma of one breast in 1969. The other
breast was subsequently removed and was
found to contain Thorotrast and fibrosis
but no tumour.
The potential radiation danger of
thorium dioxide may be small but, when
retained at one site over a long period, can
and has produced carcinomas and sar
comas of various tissues. Thorotrast was
popular as a radiologic diagnostic agent
between 1930 and 1950, then its use de
clined. Today there is an unknown number
of people who must have it in their tissues,
have the potential to develop a malignancy,
and who should be watched accordingly.
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R esu m e
En 1969, on a decouvert dans un sein un
adenocarcinome chez une femme de 60 ans qui
avait eu une mastographie bilaterale au thorotrast
30 ans auparavant. On finit par proceder a l’ablation de l'autre sein qui, a l’histologie, contenait
du thorotrast et du tissu fibreux mais pas de
tumeur.
Le danger potentiel de radiation du bioxyde de
thorium peut etre minime, mais quand cet ele
ment est retenu en une region donnee pendant
une longue periode, il peut provoquer des carcinomes et des sarcomes dans divers tissus. Le
thorotrast a eu la faveur des specialistes comme
agent de diagnostic radiologique de 1930 a 1950,
puis sa popularity a decline. II y a aujourd-hui un
nombre indefini de personnes qui doivent avoir
du bioxyde de thorium dans leurs tissus, qui
courent le danger de developper un cancer et qui
devraient etre surveillees en consequence.
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SUBARACHNOID PHENOL NERVE BLOCKS FOR R E L IE F OF PAIN
IN ADVANCED MALIGNANCY6
R. J. EVANS, M.R.C.S.[Eng.], C.R.C .S.[C]f and
I. M. MACKAY, M.D., C.R.C.P.[C],± Toronto, Out.

T his paper describes experience with the
use of intrathecal injections of phenol in
glycerin for the relief of intractable pain
in the lower one-half of the body, associ
ated with advanced malignancy. Fortynine patients—25 men and 24 women—
were treated between January 1967 and
June 1970, and the patients were followed
at monthly intervals until death,
In 1931, Dogliotti1 first described intra
thecal alcohol nerve blocks to relieve in
tractable pain in the lower one-half of the
body. In the subsequent decade many
workers reported results of this technique,
including Stern,2 Saltzstein,3 and Greenhill
and Schmitz.4 For pain associated with ad
vanced pelvic malignancies, Greenhill3' K
later combined intraspinal alcohol injec
tions with sympathectomy. Maher7 used
phenol in glycerin (1/18 to 1/20 solution)
instead of absolute alcohol. Subsequently
others mixed phenol with iophendylate
(Pantopaque) in an attempt to inhibit
selectively pain pathways. In the past de
cade Nathan,8’ 9 Stewart and Lourie,10
Mark et al.,n and Iggo and Walsh12 dis
cussed this technique and made particular
reference to its dangers and to histologic
evidence of the effect of phenol on nerve
roots. Brown,13 Maher,7 and White and
Sweet14 have made detailed reports con
cerning the results of pain management
using phenol in glycerin.
In 1969, White and Sweet13 summarized
the consensus at that time by saying: “It
is still too soon to be sure how well the
results will stand up, but we are confident
that it will be possible to avoid major
surgery in the lower half of the body in
over half of our future cases. With the
"From the Departments of Surgery and Anes
thesia, University of Toronto, Toronto General
Hospital and The Princess Margaret Hospital, To
ronto, Ont.
t Director of the Irene Eleanor Smythe Pain
Clinic; Research Associate, Department of Sur
gery, University of Toronto.
^Assistant Professor, Department of Anesthesia,
University of Toronto.

present day use of glycerin as a solvent the
results have been distinctly better than
with the earlier solution in Pantopaque,
and the rate of success is certain to im
prove with increasing experience.”
Between 1966 and 1970, over 750 pa
tients with intractable pain were referred
to the Irene Eleanor Smythe Pain Clinic in
Toronto. Approximately 75% of these had
intractable pain associated with advanced
malignancy. Forty-nine patients (approxi
mately 10% of cancer patients referred)
were assessed by a team of doctors, and
chosen for subarachnoid injection of phenol
in glycerin. One of us (I.M .M .) did most
of the nerve blocks on 28 patients (43 of
73 blocks); those on the remaining 21 were
done by other specialists in anesthesiology
or neurosurgery, all of whom had experi
ence with this technique.
A gents

and

P rocedubes

The intrathecal block procedures were
all carried out in an operating room under
strict asepsis, using a solution of phenol in
glycerin prepared to order by Toronto
General Hospital pharmacy ( each cubic
centimetre of the solution contained 0.05
c.c. of phenol, i.e. 5% phenol in 95%
glycerin).
The patient is positioned with the pain
ful side down and the operating table is
adjusted so that the point of injection, and
therefore the area to be treated, is at the
lowest point in the curve of the spinal
column.
After making a skin wheal with a local
analgesic, a 20-gauge (or larger) needle
is inserted into the subarachnoid space. A
smaller needle is not suitable because of
the viscosity of the glycerin. When the
needle has been inserted and a free flow
of spinal fluid has been established, the
patient is rotated posteriorly about 30°
and the phenol-in-glycerin is injected into
the subarachnoid space over a period of
five to 10 seconds. Because the solution is
heavier than cerebrospinal fluid, gravity
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directs it downwards from the point of in
jection on to the immediately adjacent
nerve roots.
In this series, we usually injected about
1 c.c. In a few cases, only 0.75 c.c. was
injected, and in a small number, when the
effect of a previous injection had proved
inadequate, we used 1.3 c.c. to 1.5 c.c.
The patient was kept in the 30° position
for 30 minutes after injection and then re
turned to bed and instructed to lie flat—
not necessarily supine—for 24 hours.
Intrathecal injection o f phenol 5% in
glycerin is followed quickly by a sen
sation of warmth and sometimes by mild
paresthesia in the distribution of the roots
affected. Anesthesia of these roots usually
follows in a few moments.
In this series, bilateral pain was treated
by an intrathecal phenol block on the most
painful side. In some cases we followed
this by a block on the other side three or
four days later. Some patients improved so
much after one injection that the second
side was not done.

they presented at the Pain Clinic, 31 had
genitourinary symptoms, including diffi
culty initiating micturition or incontinence
of urine, or were already on continuous
catheter drainage. An equal number had
signs or symptoms in the central nervous
system, including alteration in sensation to
pinprick and light touch, deep reflex
changes, loss of sphincter tone or dimin
ished muscle power in the lower extremi
ties. Of the 34 patients who had died from
their disease at the time of this report, 25
had lived one to three years from the time
of their initial diagnosis. Forty-one had
survived for longer than three months after
the initial nerve block.
R esults

The severity of pain and degree of relief
were recorded in the patient’s own words,
and at frequent intervals we related it to
the analgesic drug requirement and objec
tive assessment. Table II illustrates the
duration of the effect of phenol.
TABLE II. —

Selection

of

P atients

Of the 25 men and 24 women in this
group, 15 were still alive in January 1971.
Six of the 49 were under 40 years of age,
18 were between 40 and 59, and 25 were
more than 60 years old. The sites of
primary tumour are illustrated in Table I,
TABLE I .— S it e
Colon and rectum
Female genitalia
Genitourinary system
Others

of

P r im a r y T u m o u r

22
13
2
12

and it will be noted that 37 patients had
recurrences from primary sites in the colon,
rectum and female genitalia. All patients
had localized pain at various sites in the
lower one-half of the body.
Thirty-two had a single block, 10 had
two blocks, and seven had three, so that
49 patients had 73 subarachnoid injections
of phenol in glycerin. All 49 patients had
had intractable pain from one to 36
months, with a mean duration of nine
morphs. Fifteen had intractable pain from
one to three months, and the remaining 34
had pain from three to 36 months. When
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D u r a t io n o f

Less than 1 week
Less than 1 month
1 —3 months
3—6 months
More than 6 months
Unknown
Total

Effect

of

P henol

3f| 60%
22
3
1
2
73 Blocks

All patients obtained complete relief of
pain at the time of the block. Thirty-eight
blocks (5 0 % ) produced relief that lasted
for less than one week, and seven more
for one to four weeks, after which the pain
returned in its former severity, i.e. 45 of
the nerve blocks relieved pain for less than
one month. Twenty-two blocks gave relief
for one to three months, and four blocks
for more than three months. The follow-up
on the other two is not known. Eight pa
tients of the 34 who died from their disease
had less severe pain up to the time of
death, but of the eight patients who died
before three months, five had complete
relief of symptoms. These results compare
favourably with those of Gordon and
Goel,18 and White and Sweet.14 Forty-five
of these 49 patients needed other anal
gesics to control their pain after the phenol
nerve block.
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C o m p lic a t io n s

Nine patients (1 8 % ) developed compli
cations and side effects that we attributed
to the phenol block. In three, we could not
withdraw regular morphine medication; in
two, the injection precipitated urinary in
continence, requiring continuous catheter
drainage. One developed foot-drop and
pain in the foot, and two developed peri
pheral dysesthesia in the lower extremities,
with associated weakness in a lower ex
tremity in one.
E v a l u a t io n of M ultiple B locks

Thirty-two patients had a single phenol
nerve block. Two died within one month
and, of the remaining 30, nine had relief of
pain for more than one month. O f 10 who
had a second nerve block, four got relief
that lasted for more than one month, Of
those who obtained no benefit from a
second block, only one got relief for more
than one month after a third block.
D iscussion

Arbitrarily we have defined “intractable
pain” as that which has been present for
more than one month without remission
in spite of treatment. Intractable pain as
sociated with advanced malignancy is for
tunately uncommon,17 but it is a most
difficult social and medical challenge. The
assessment of ultimate prognosis following
initial management of malignancy is no
toriously difficult and commonly inaccurate.
Therefore, in making recommendations
concerning these seriously ill patients, we
should choose the treatment in the light of
the ultimate prognosis. With the advent of
thalamotomy and percutaneous cordotomy
for the relief of intractable pain, it has be
come increasingly difficult to select the
correct treatment for this category of
patient.
With phenol injections, White and
Sweet18 treated 30 patients for intractable
pain associated with colonic, rectal, and
recurrent cancer of the female genitalia.
Of these, five had no recurrence o f pain to
death. In our series, eight of 49 were free
of pain until death.
The procedure described is simple and,
if necessary, can be performed at the bed
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side. It carries negligible morbidity, but
the effect is only of short duration, and
we do not recommend this procedure for
those who will probably live for longer
than one month. Those who are expected
to live longer should be referred for defini
tive neurosurgical treatment, such as per
cutaneous cordotomy or thalamotomy.
Although a high percentage of our pa
tients had neurologic and genitourinary
symptoms because of advanced disease,
this did not seem to affect the results of
the phenol block. W e felt these patients
probably fitted into the category that
Maher7 described (those with dural in
filtration and carcinoma coated ganglia),
and phenol nerve block worked even
though we didn’t expect it to. W e believe
that if the first attempt produces short
lived pain relief, a second attempt is
worth while, but that subsequent phenol
blocks will probably be ineffective.
Su m m a r y

Forty-nine patients with intractable pain
associated with advanced malignancy were
treated by intrathecal injections of 5%
phenol in glycerin. Only eight patients had
complete relief of pain until death, and
90% of these patients needed other anal
gesics to control their pain. Eighteen per
cent of patients had some type of compli
cation or side effect. Patients with intract
able pain in the lower one-half of the
body, who are expected to live longer than
one month, should be referred at once for
definitive neurosurgical maneuvers, and
phenol nerve blocks should be reserved for
those with intractable pain and a very
short expectation of life. No more than two
nerve blocks should be attempted, because
further nerve blocks probably will not pro
duce relief for longer periods. Phenol
blocks may also be used as an adjunct to
unilateral cordotomy when it is unaccept
able or inadvisable to perform the bilateral
procedure.

We wish to thank all the physicians who have
referred patients with intractable pain to the
Irene Eleanor Smythe Pain Clinic for their co
operation in supplying us with details of follow
up, and to the ancillary staffs at The Princess
Margaret Hospital, Queen Elizabeth Hospital, and
Toronto General Hospital for their invaluable
assistance. We would also like to thank Mrs. R.
Topp for her secretarial assistance.
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R esu m e
Nous avons cherehe a soulager la douleur
opiniatre de 49 malades souffrant d’un cancer
avance, au moyen d’injections intrathecales d’une
solution glycerinee a 5% de phenol. Iluit malades
seulement furent soulages completement jusqu’a
leur mort et 90% d’entre eux devaient prendre
d’autres analgesiques pour maitriser la douleur.
On a note certaines complications ou certains
effets secondaires chez 18% des malades. Il importe de soumettre sans delai au neurochirurgien
le cas des malades dont la douleur rebelle siege
dans la moitie inferieure du corps et qui ont une
esperance de vie de plus d’un mois. L ’anesthesie
tronculaire devra 6tre reservee aux seuls malades
souffrant de douleur opiniatre et qui n’ont que
peu de temps a vivre. On ne devra proceder qu’a
un maximum de deux anesthesies tronculaires,
car de nouvelles anesthesies risquent de ne pas
apporter de soulagement pendant des periodes
plus longues. On pourra egalement utiliser ce
procede comme adjuvant d’une cordotomie unilaterale, dans les cas ou il est inacceptable ou a
deconseiller de proceder a la cordotomie bilaterale.
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who month by month assist the Editor of The Canadian Journal o f Surgery by con
tributing book reviews, make a significant contribution to continuing medical educa
tion. The Editorial Board and the Editor wish, at this time, to acknowledge with
gratitude the assistance, during 1971, of their colleagues whose names appear below.
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contents. The Concise Oxford Dictionary
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figurent dans I’Index Medicus. Les renvois aux
livres comprendront dans l’ordre: le nom de
Tauteur, ses initiales, le titre de l’ouvrage, le
numero de l’edition (p. ex. deuxieme ed.), la
ville et le nom de la maison d’edition, et
l’annee de la publication; enfin, le numero de
la page s’il s’agit d’un renvoi precis. Pour
examples, voyez Tissue de janvier 1971 et ceux
a venir.
Illustrations
Le journal accepte de publier gratuitement
un nombre raisonnable d’illustrations en noir
et blanc. Les reproductions de cliches en couleurs seront publiees aux frais de Tauteur. Les
photographies seront imprimees sur papier brillant, ne seront ni montees ni calibrees et d’un
format maximum de 6" x 8". En ce qui concerne les radiographies, nous demandons des
copies et non pas Yoriginal. On devra toujours
foumir un agrandissement de microphoto
graphies. Il ne faut jamais ecrire ou dactylographier un texte quelconque sur les photo
graphies. Une legende les identifiant pourra
etre jointe au dos. Dans les illustrations montrant des malades, ceux-ci ne pourront etre
reconnus, a moins qu’ils n’en aient donne le
consentement ecrit prealablement a la publica
tion. Les graphiques et diagrammes seront dessines a l’encre de Chine sur un bon papier a
dessin blanc. Le lettrage devra etre ecrit en
caracteres assez grands pour que, apre reduc
tion proportionnelle au format du Journal, ils
soient encore lisibles. Les legendes devant
accompagner les illustrations seront dactylo
graphies sur une feuille independante du
texte. Les illustrations ne seront ni roulees ni
pliees.
Langue vehiculaire
II doit etre clairement etabli que les collaborateurs ont pleine liberte de soumettre leurs
articles en francais ou en anglais, a leur choix.
L ’acceptation de Tarticle sera entierement inde
pendante de la langue choisie par Tauteur. Si
le collaborateur le desire, il peut decrire le
contenu de Tarticle en un sommaire ne depassant pas 300 mots et dans une langue differente
de la langue choisie pour Tarticle lui-meme.
Par exemple, un article ecrit en frangais doit
comporter un resume en frangais et peut, si
Tauteur le desire, etre accompagne d’un som
maire plus detaille en anglais.
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ASPIRIN, PLA TELETS AND STROKE. Back
ground for a Clinical Trial. Compiled and
edited by William S. Fields and William K.
Hass. 153 pp. Illust. Warren H. Green, Inc.,
St. Louis, 1971. $10.50.

This little book contains the verbatim report
of a meeting held in Houston, Texas, to dis
cuss the feasibility of a co-operative study or
a controlled clinical trial of aspirin, in an at
tempt to determine whether or not it could
be used to modify platelet emboli. If so, the
management of transient ischemic attacks
might be altered.
The book is an excellent description of the
current status of radiologic interpretation of
atherosclerotic lesions in the vessels of the
head and neck. There is an extensive descrip
tion of the actions of platelets and the role of
aspirin on platelet function. One section deals
with the effects of aspirin as a specific drug
in actions other than those on platelets and
reflects the current knowledge of aspirin
metabolism. The final section describing the
problems of controlled clinical trials is well
worth reading.
With the current interest in platelet
metabolism and the actions of blood and
blood constituents on the vessel wall, this book
is timely and appropriate. It is easy to read
and will serve as a reference for workers not
specifically involved in this field. Anyone
interested in the problems of thromboembol
ism, whether arterial or venous, will find this
book profitable. It has immense clinical
significance for everyone in surgery and its
specialties.
CHEST INJURIES. Physiologic Principles and
Emergency Management. Emil A. Naclerio. 383
pp. Illust. Grune & Stratton, Inc., New York,
1971. $28.50.

It was a pleasure for the reviewer to read
this book, which was also given to his resident
to review; he, too, heartily endorsed it as a
valuable text in the diagnosis and treatment
of acute chest injuries. As the author states,
this is not an exhaustive treatise but it out
lines, with commendable brevity and clarity,
the management of every conceivable cause of
chest trauma that can occur in civilian prac
tice. The book to some extent is dogmatic
hut this dogmatism is refreshing because it
comes from an individual who has un
paralleled experience with peace-time injuries
to the thoracic cage and intrathoracic struc
tures. The references are up to date and rele
vant and are not inserted throughout the text
to distract the reader.
Dr. Naclerio has emphasized the fact that
the management of such patients is a team
effort involving multiple disciplines and all
surgical specialties as well as paramedical

personnel. This book can be recommended to
everyone associated with the management of
the acute chest injury, whether as a con
sultant, a resident or a medical student. It
should not only be available in every library
and emergency department but should be
compulsory reading for those involved in the
management of patients with chest trauma.
CONGENITAL ABSENCE OF TH E EAR. Eric
W. Peet. 39 pp. Illust. E. & S. Livingstone
Ltd., Edinburgh; Longman Canada Limited,
Toronto, 1971. $7.25.

Mr. Eric Peet, the former Director of the
Department of Plastic Surgery, Churchill Hos
pital, Oxford, has demonstrated a lifetime
interest in congenital absence of the ear. Un
fortunately, this text is a posthumous credit
to his sincere depth of understanding of both
the patient’s regional deficiencies and the
surgeon’s frustrations.
This text contains his personal experience
after many years’ attempt to improve the re
sults of total ear reconstruction. There is a
natural progression throughout the text as the
author demonstrates his own imaginative con
cepts coupled with the published experiences
of others.
He divides his text into four distinct
chapters;
general considerations,
general
principles, details of reconstruction of the
pinna and construction of a sound conduc
tor and the external auditory canal.
Mr. Peet outlines most of the shortcomings
and problems encountered in this type of
surgery. In the appendix he has presented a
pictorial record of six patients with microtia
and has demonstrated the end results.
Although this is a specialized subject and
of only limited appeal, it should, hopefully,
find a permanent place in the library of most
reconstructive surgeons. The author’s thought
ful dedication is evidenced throughout the
text and further reinforced by the efforts of
his associates Messrs. Patterson and Batstone.
This is an inexpensive yet worthwhile mono
graph.
FETTSTO FFW ECH SELSTO RUN G EN .
IHRE
ERKENNUNG UND BEHANDLUNG. Edited
by Gotthard Schettler. 184 pp. Illust. Inter
continental Medical Book Corp., New York;
Georg Thieme Verlag, Stuttgart, 1971. DM
24,00. $7.00 (approx.). Paperbound.

Problems related to fat metabolism are dis
cussed frequently in the professional journals
and also in the lay press. The publication of a
monograph devoted to these problems, there
fore, is timely. In the first chapter, the
clinical picture of the five types of hyperlipo(Continued on Adv. p ag e 20)

The
Second Step
in Treating
Shock

vasoden'tine, n. ( vaso-. and L. tints. J m tis . a tooth.) in an
atomy, a modification o f dentine in which capillary tubes
o f the primitive vascular pulp remain uncalcified and carry
red blood into the substance o f the tissue.
vas"6-di-la, tion. n. expansion o f a vessel: particularly o f W
arterioles resulting in increased blood flow.
v»s"d-di*lit,or, a. producing dilatation o f the blood vessels.

|

vas"o-dMsit'or, n. a vasodilator nerve or drug.
vaso form 'ah v e. a. in physiology, building up new blood y .
vessels or vascular tissue.

---

.

vas-o-hy-per-ton'ic, a. same as vasoconstrictor.

y

vas-d-by-po-ton'tc, a. same as vasodilator.
vas"oin*hib'itor, n. any agent or drug that inhibits the action
o f the vasomotor nerves.

vas',oinhtb/i t d n , a. hindering the action o f the vasomotor

i

nerves.

vas-o-mS'tton, n. in anatomy, the contraction or dilatation o f......
the caliber o f a blood vessel.
;|
vas-o-mo'tor, a. (raso- and m otor.) in physiology, regulating
the size <i.e.. caliber) of blood vessels by causing contraction

Volume replacement - accompanied by appropri
ate antibiotic therapy when necessary - is the es
sential first step in shock therapy.
However, when volume replacement alone fails to
reduce peripheral resistance, improve tissue per
fusion and restore cardiac output, additional drug
therapy is required.

vasodilationthe important second step
Authorities report that a growing trend in the
treatment of severe shock is the use of vasodila
tors to restore haemodynamic balance.
One author1suggests that there are three general
types of drugs that induce vasodilation:
• those, such as isoproterenol, which produce di
rect vasodilation:
• those, such as phentolamine, which produce
vasodilation by blocking the vasoconstrictive ef
fects of epinephrine, norephinephrine, and related
substances;
• those, such as Solu-Medrol, which produce
vasodilation by unknown means.

Each of these drugs works to reduce vascular resistance and thus lessen the workload on the
heart. The difference among them is in the quality
of vasoactive response which each induces.
Isoproterenol - an effective cardiotonic agent as
well as a peripheral vasodilator - produces its
greatest amount of vasodilation in the skeletal
muscle beds which are adequately perfused in
most shock patients. Vasodilation is only minimal
in the viscerocutaneous beds where the need for
blood is greatest.
When isoproterenol is given alone in sufficient
amounts to increase cardiac output and reduce
peripheral resistance, tachycardia, arrhythmia, or
tachyphylaxis may occur.
Phentolamine is one of several drugs which pro
duce vasodilation by blocking the effects of the
endogenous catecholamines and thereby reduc
ing vasoconstriction produced by increased sympathetic tone.
The drug takes effect within 5 to 15 minutes and is
short-acting. Because of this, it must be given as
a continuous infusion requiring constant and care
ful monitoring. Its effects are extremely difficult to
regulate by the intravenous drip technique.
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Dosage and Administration: In severe shock, ad ju n ctive use of
S o lu -M e d ro l may aid in achieving haemodynam ic restoration.
C o rtic o id the rap y sho uld not replace standard m ethods of
co m b a tin g shock, but present evidence in dica tes th a t c o n c u r
re nt use o f large doses o f c o rtic o id s w ith o th e r m easures may
im p ro v e s u rv iv a l ra tes. In p a rtic u la r, la rg e p h a rm a c o lo g ic
doses o f S o lu-M edrol have been proved useful in bacteraamic
o r e n d o to xin shock, haemorrhagic shock, tra u m a tic shock, and

c a rdioge nic shock. The fo llo w in g S olu-M edrol doses are sug
gested by various authors:

Author

Dose

Repeat

Oaks2
W e il3
M e lb y'
Cavanagh5
D ietzm an4

100 mg
200 mg
250 mg
15 m g /k g
30 m g /k g

every 2 to 6 hours
100 mg every 4 to 6 hours
every 4 to 6 hours
every 24 hours
in 4 hours if needed

Therapy is initia te d by a d m inistering S olu-M edrol intravenously
over a period o f one to several m inutes. In general, therapy
should be con tinued o n ly u n til the pa tient's con dition has sta
bilized - usually not be yond 48 to 72 hours.

r

Solu-Medrol
*

a different type of vasodilator
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Solu-Medrol, a corticosteroid, produces vasodila
tion whengiven in massive(pharmacologic)doses.
Although its exact mode of action is not known, it
is thought that the drug has at least two effects:1

,
’

'
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• it slows transmission of sympathetic nerve im
pulses thus delaying the release of the endoge
nous catecholamines
• it preserves the integrity of the capillaries in the
face of anoxia
These and other effects produce measurable decreases in the resistance of the viscerocutaneous
microcirculation.

Clinical confirmation of corticosteroid
effectiveness and safety in shock

“ The corticosteroids are effective in most patients
and are, we believe, the best vasodilators availa
ble to the practicing physician.”
Dietzman, R.H., et al. (1970). Pharm. for Phys., 4(8):1.

“ ...we believe that until physicians develop awider
experience with rapid-acting adrenergic blocking
agents, it is safer to use hydrocortisone [cortico
steroid] as the initial treatment of apparent irre
versible shock in patients.”
Lillehei, R.C.,et al. (1964). Ann. Surg., f60(4):682.

T

The amount of vasodilation produced by SoluMedrol is dependent on the dose. The steroid
should be administered as a single intravenous
v bolus over a 3 -to 5-minute period.

V'

^

Because it produces a gradual response, SoluMedrol is easily monitored by the attending phy'
sician. It can be administered quickly and easily
T in a single intravenous bolus thus eliminating the
need for the intravenous drip technique. Adverse
r effects associated with short-term pharmacologic
doses of Solu-Medrol are uncommon.
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S o lu-M edrol may be given by intravenous in je ctio n , by in tra 
venous infu sio n, or by intram uscu lar in je ctio n . The preferred
m ethod fo r in itia l em ergency use is intravenous in je c tio n .

Supplied: M ix-O -V ials c o n ta in in g 40 m g, 125 mg, 500 mg, and
the new 1 Gm vial w ith w a te r fo r in je c tio n , m e th ylp re d n iso lone as m e thylpre dniso lo ne so d iu m s u c c in a te .

Cautions: The general precautions and c o n tra in d ic a tio n s to
s y s te m ic c o r tic o s te r o id th e ra p y a p p ly to th e use o f S o lu M e drol. H owever, w hen used fo r m edical em ergencies o r in
s h o c k -lik e s ta te s , th e p o s s ib le life s a v in g e ffe c ts m u st be
w eighed against the po ssib le undesired horm onal effects.

References: 1. Dietzman, R.H., et al. (1970). Pharm. for Phys.,4(8):1.
2. Oaks, W.W., et al. (1967). Geriatrics, 22 120. 3. Weil, M. H., et al.
( 1964). Ann. Int. Med., 60:384 . 4. Melby, J.C. (1964). New Phy„ (3:426.
5. Cavanagh, D., et al. (1968). Amer. J. Obstet. & Gynec., 702:13.
6. Dietzman, R.H.,et al. (1967). GP, 36:135.

In the tre atm ent o f sho ck, S olu-M edrol should be a d ju n c tiv e
to co n vention al s up portive therapy such as flu id re placem ent,
etc. A lthou gh adverse e ffe cts associated w ith high -do se s h o rt
term c o rtic o id the rap y are uncom m on, peptic ulc e ra tio n m ay
occu r.
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proteinemia is described briefly. The physico
chemical characteristics of the different types
of plasma lipoproteins are described in some
detail. The main part of the monograph is
devoted to a description and a discussion of
the dietary treatment of various hyperlipoidemias, the importance of the cholesterol levels,
the relationship between
nutrition and
coronary infarction and the prevention of
coronary disease by dietary means. The last
chapter is devoted to a brief description of
the role of essential fatty acids and of pro
staglandins. Some of the material presented is
rather controversial. The reader may not
agree with some of the authors’ conclusions,
but, nevertheless, they present an interesting
review of present opinions. Dietary measures
aimed at decreasing the levels of cholesterol
and of lipids are emphasized whereas the
relationship between sugar consumption and
atherosclerosis is rejected.
THE HAND. Lee Milford (from the 5th edition
of Campbell’s Operative Orthopaedics, edited
by A. H. Crenshaw). 282 pp. Must. The C. V.
Mosby Company, St. Louis, 1971. $20.50.

This book is a reproduction of Chapter IV
of the fifth edition of Campbell’s Operative
Orthopaedics . In 259 pages, of which almost
one-half consist of illustrations, the author has
attempted to cover all facets of hand surgery.
Starting with basic plastic surgery techniques
and passing through hand injuries, amputa
tions, reconstruction, rheumatoid and cerebral
palsied hand, he completes the book with
sections on congenital anomalies, tumours of
the hand and pyogenic infections.
Most of the book is a detailed discussion of
operative technique with little discussion
of pathophysiology and almost no comparison
of the results of these techniques. The entire
book is basically a reproduction of the best
artic’es on each aspect of hand surgery. The
illustrations are nearly all exact reproductions
from these articles. For instance, the best
classic drawings of J. W. Littler are included.
The illustrations from an article by W. L.
White on tendon transfers, which appeared in
the Surgical Clinics o f North A m erica in 1960
are reprinted in their entirety.
There is considerable imbalance which can
not be explained solely by trying to cover too
much in too few pages. For instance, two
pages are devoted to the Allen test for vascu
lar insufficiency, while no mention is made of
malignant skin tumours in the section on
tumours of the hand. Similarly, on the rheu
matoid hand, three pages are devoted to the
Fowler and Vainio arthroplasties for the meta
carpal joints, while joint prostheses are dis
missed in one sentence. It also appears as
though the author has little experience with
several of the techniques mentioned, such as
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the Howard technique for the management of
flexor and extensor tendon adhesions.
This book, which will be useful mainly to
the student commencing a study of hand sur
gery, provides an extensive bibliography of the
better articles on this subject. It will prove of
little use to the advanced student or experi
enced hand surgeon looking for new tech
niques or comparisons of the results of known
methods.
HEPATIC FAILURE. Henry Brown. 137 pp.
Illust. Charles C Thomas, Publisher, Springfield,
111.; McGraw-Hill Company of Canada, To
ronto, 1970. $10.50.
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KURZE
HNO-OPERATIONSLEHRE
FUR
ARZTE UND STUDIERENDE. Band 1: Op
erative Eingriffe an Nase, Nasen- und Mundrachen, Hypopharynx, Kehlkopf und ausserem
Hals. Gerhard Theissing. 308 pp. Illust. Inter
continental Medical Book Corp., New York:
Georg Thieme Verlag, Stuttgart, 1971. DM
49,00. $14.30 (approx.). Paperbound.
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This excellent little book presents an up-todate summary of present knowledge of the
anatomy and physiology of the liver together
with the pathophysiology of hepatic failure.
From these considerations are derived the
rationale for therapy.
The book is clearly written. Line drawings
explain points well and the list of references
for each chapter is exhaustive enough to
allow the reader to delve deeper into the
subject if he so wishes.
The book is an admirable summary of
present knowledge and will he particularly
suitable for final-year medical students and
residents wishing to learn about the subject,
and for experienced practitioners who wish
to review and update their understanding of
the whole field of hepatic function. The book
is short enough to be read through without
an excessive use of time, yet complete
enough to _ -ovide a good general understand
ing.

As the title indicates, the book was written
for those who are starting the study of sur
gery, covering the areas noted in the title.
In a short span this book gives maximum
information about basic principles of surgery
in general, about the methods of surgery for
various areas of the face, head and neck.
The individual chanters of the book cover
main surgical procedures for treatment of in
flammatory processes in these regions, the
surgery of tumours, congenital anomalies, in
juries and post-traumatic deformities.
The description of operational methods is
thorough, with steps of the surgery presented
in chronological order, the most popular opera
tions being demonstrated with schematic draw
ings. The details of the operative treatment
using different surgical procedures is very
good for those intending to work in surgery.
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This book is a valuable aid to physicians
and students who require a generalized
picture of surgical problems of the head,
face and neck, where the interests of a few
surgical specialists meet.
LUNGENMYKOSEN. Vortrage der Friihjahrstagung der Rheinisch-Westfalischen Vereinigung
fur Tuberkulose- und Lungenheilkunde am 14.
Marz 1970 in Diisseldorf. Edited by Hans
Bartseh. 64 pp. Illust. Intercontinental Medical
Book Corp., New York; Georg Thieme Verlag,
Stuttgart, 1971. DM 22,00. $6.40 (approx.).
Paperbound.

Papers presented at a meeting on fungus in
fection of lungs held in W est Germany in
1970 are presented in this short monograph.
Emphasis is placed on the infections occurring
in Europe. The infections occurring in other
parts of the world, including histoplasmosis,
coccidioidomycosis, blastomycosis and sporo
trichosis, are mentioned but treated very
briefly. For this reason, the book is of limited
interest to practitioners in this country.
A PRACTICE OF THORACIC SURGERY. 3rd
ed. A. L. d’Abreu, J. Leigh Collis and D. B.
Clarke. 652 pp. Illust. Edward Arnold (Pub
lishers) Ltd., London; The Macmillan Company
of Canada Limited, Toronto, 1971. $49.50.

The third edition of this book does not live
up to the high quality of its predecessors. The
complexity of thoracic surgery led Dr.
d’Abreu to enlist the help of Drs. Collis and
Clarke to expand this volume. Drs. Collis and
Clarke have added substantially to the value
of this edition but they have attempted to
cover too much, and many areas have re
ceived rather cursory treatment. It would,
perhaps, be better to leave out an entity than
to mention it just for the sake of completeness.
The section on pacemakers is inadequate.
The sections on cardiac surgery, although
helpful in many areas, gloss over many prob
lems, e.g. in the area of valve replacement,
to such an extent that it is too sketchy for
the specialist. This reviewer would argue with
the authors’ selection of atrial-femoral bypass
for thoracic aortic aneurysms. Femorofemoral
bypass is much safer and simpler. Also the
approach to an aorticopulmonary window
through the pulmonary artery is much less
preferable than the transaortic approach. In
short, the section on the surgery of the heart
and great vessels is a distinct disappointment.
The strength of this book lies in the sec
tions on the lung, the esophagus and the
diaphragm. These areas are masterfully
covered by experts whose experiences are
almost without parallel.

Tandearil
oxyphenbutazone

G-2325-71

pu|| information is available
on request

Geigy Pharmaceuticals
Montreal 308, P.Q.
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Although this text remains an important
contribution in its field primarily because it
reports the experience from one major
thoracic centre, it cannot be recommended
for the specialist thoracic surgeon. It would
be of more value to a general thoracic surgeon
or to the general surgeon who requires a
lucid text to which to turn for advice. The
bibliography at the end of each chapter could
be updated, because it is not comprehensive
(perhaps it was not intended to be) and in
many areas the most recent references are
two to three years old. The illustrations and
the quality of publication are excellent but
the price ($50.00) will deter the average
practitioner.
NEPHRON FAILURE. Conservation. Substitu
tion. Replacement. John B. Dossetor and M.
Henry Gault. 303 pp. Illust. Charles C Thomas,
Publisher, Springfield, 111.; McGraw-Hill Com 
pany o f Canada, Toronto, 1971. $23.75.

This excellent text covers the complete
spectrum of renal failure and its diagnosis and
treatment. Physiologic principles are used as
the basis for treatment and one is impressed
with reference to the large personal experi
ence of the authors throughout this mono
graph. Emphasis is placed on the require
ment for knowledge of the entire spectrum
of renal failure so that management at one
stage does not compromise treatment at a
later time in the disease.
The practical aspects of management are
presented in a most readable and helpful
form; for example, the supplier of bread made
from glutin-free flour, important in manage
ment of some patients in the first stage of
renal failure, is listed. The authors, although
actively involved in renal transplantation, re
main objective and emphasize the comple
mentary functions of dialysis and transplanta
tion in the treatment of end-stage renal dis
ease.
The text considers the effect of nephron
failure on other organ systems, on drug dos
age, on carbohydrate, fat and protein metabol
ism, all of which make up 13 of the 22
chapters.
All physicians and surgeons who must
evaluate and treat patients with renal failure
will find this a most useful and mature sum
mary of current thought and practice.
PATHOLOGISCHE ANATOMIE. Vol. I. AHgemeine Pathologie. 3rd ed. Hans Ulrich Zollin
ger. 336 pp. Illust. Intercontinental M edical
Book Corp., New York; Georg Thieme Verlag,
Stuttgart, 1971. D M 12,80. $3.75 (approx.).
Paperbound.

This small book, which first appeared in 1968,
is already available as a revised third edition.
In the meantime it has been translated into
French, thus it appears to be very popular.
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In the first volume, the author, who is Pro
fessor of Pathology at the University of Basle,
has reviewed the various aspects of general
pathology in a rather didactic manner with
out getting involved with some of the more
controversial topics. The areas covered in
clude: malformations, regressive changes, pro
gressive changes, general pathology of respira
tion and circulation, inflammation, tumours
and disturbances caused by chemical and
physical means such as heat, electricity, and
irradiation. The book is well organized but
somewhat difficult to read because it is written
in a telegraphic style and uses abbreviations
rather extensively. The book is directed pri
marily to medical students, but can also be
recommended to graduates preparing for
specialty exams, if they have a reasonable
reading knowledge of German.
MENISCUS LESIONS. Practical Problems of
Clinical Diagnosis, Arthrography and Therapy.
P. Ricklin, A. Riittimann and M. S. del Buono.
American translation by Karl H. Mueller. 142
pp. Illust. Intercontinental M edical Book Corp.,
New York; Georg Thieme Verlag, Stuttgart,
1971. DM 59,00. $16.35 (approx.).

Although the title suggests that this is a text
book on meniscus injuries, it is really a mono
graph on arthrography of the knee. Eightysix of the 132 pages are devoted to this sub
ject.
The remaining sections dealing with
anatomy, pathogenesis, diagnosis and treat
ment are brief and not as complete as those
presented in many standard texts on the sub
ject. This reviewer would disagree with
certain statements on the function of menisci.
Some aspects of proposed treatment are also
controversial. The authors, for example, ad
vocate the removal of menisci in tibial plateau
fractures—a practice that most surgeons would
oppose.
The section on arthrography is excellent. A
double contrast, air and a water-soluble
iodide, is used. The technique is meticulous
and well described. There are superb illus
trations of both normal and pathologic
menisci. The latter are cleverly demonstrated
by combining high-quality photographs of the
arthrogram with line drawings to clarify the
findings and compare them with the patho
logic specimen. This three-part presentation
of most types of meniscal tear is valuable,
both in teaching assessment of the arthrogram
and in convincing skeptics of its worth.
Although it may be somewhat overpriced,
this monograph is recommended to any sur
geon or radiologist beginning to use knee
arthrography as a diagnostic tool, and to
those wishing to improve the quality of their
present films. The technique is particularly
important and the excellent illustrations will
be a valuable aid in interpretation.
(Continued on Adv. page 27)

Now available for intravenous administration.

In suspected as well as documented gram
negative septicemia, or in imminent development of septicemia from serious respiratory or
urinary tract infections, or wounds and burns
complicated by sepsis... because of its broad
gram-negative spectrum, its value in selected
staphylococcal infections and its established
clinical efficacy.
GARAMYCIN Injectable (40 mg (base)/ml)
GARAMYCIN Pediatric Injectable (10 mg (base)/ml)

T
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INDICATIONS:

GARAMYCIN is indicated in the treatment of serious infections caused
by proven susceptible organisms.
In suspected or documented gram-negative septicemia, particularly
when shock or hypotension are present, GARAMYCIN should
be considered for initial antimicrobial therapy. In staphylococcal
infections, GARAMYCIN should be considered when conventional
antimicrobial therapy is inappropriate or when susceptibility
testing and clinical judgment indicate its use.

—•

ADMINISTRATION AND DOSAGE:
INTRAMUSCULAR/1NTRAVENOUSft ADMINISTRATION:
A. Urinary Tract Infections

The usual dosage in lower urinary tract infections is 0,8 - 1,2 m g/kg/d
in two or three equally divided doses for seven to ten days. For
increased antibacterial activity it may be advantageous to alkalinize
the urine. Infections of the upper urinary tract, such as pyelonephritis,
should be treated according to one of the schedules for systemic
infections.

r
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!SCHEPING

Garam ycin
initial therapy
tD u e to g ra m -n e g a tiv e o rg a n ism s
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B. Systemic Infections - Normal Renal Function

Y

The treatment of systemic infections in patients with normal renal
function requires a dosage of 3 mg/kg/day in three equally divided
doses. A course of seven to ten days of treatment will usually
clear an infection due to a susceptible organism. In patients with
life-threatening infections, dosages up to 5 m g/kg/day should be
administered in three or four equally divided doses. This dosage
should be reduced to 3 m g/kg/day as soon as clinically indicated.
C. Patients with Impaired Renal Function
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In patients with diminished renal function or those undergoing
intermittant hemodialysis, the dosage has to be adjusted depending
on the degree of renal impairement.
For detailed information consult the product monograph or the Schering
Representative.
" ff INTRAVENOUS ADMINISTRATION
The usual effective dosage of GARAMYCIN Injectable administered
intravenously is 3 mg/kg/day in three equally divided doses.
For intravenous administration, a single dose (1 mg/kg) ot
GARAMYCIN Injectable is diluted in 100-200 ml of sterile normal
saline or 5% dextrose. The solution is infused over a period of one
to two hours and repeated two to three times a day. The usual
duration of treatment is seven to ten days.
PRECAUTIONS:
Ototoxicity:

Gentamicin, like other aminoglycosides, has produced ototoxicity in
experimental animals and man. It is manifested by damage to
vestibular function and may be delayed in onset. Damage has occurred
in patients who were uremic, had renal dysfunction, had prior
therapy with ototoxic drugs or received higher doses or longer therapy
than those recommended. The concomitant use of ethacrynic
acid and furosemide should be avoided.
The physician should strongly consider discontinuing the drug if the
patient complains of tinnitus, dizziness or loss of hearing.
Serum GARAMYCIN levels in excess of 12 Mg/ml should be avoided.
Nephrotoxicity:

Nephrotoxicity manifested by an elevated BUN or serum creatinine
level o ra decrease in the creatinine clearance has been reported with

GARAMYCIN. In most cases these changes have been reversible.
Neuromuscular Blocking Action:

Neuromuscular blockage and respiratory paralysis have been reported in
animals. The possibility of this occurring in man should be kept in mind
particularly in those patients receiving neuromuscular blockinq aqents
ADVERSE REACTIONS:

Among other adverse reactions reported infrequently and possibly
related to GARAMYCIN are elevated SGOT, increased serum bilirubin,
granulocytopenia and urticaria. Reactions reported rarely and
possibly related to GARAMYCIN include drug fever, hypotension,
hypertension, itching, hepatomegaly and splenomegaly.
OVERDOSAGE:

Peritoneal or hemodialysis will aid in the removal of GARAMYCIN
from the blood.
PRESENTATION:

GARAMYCIN Injectable 40 m g/m l: GARAMYCIN Injectable is packaged
in 2 ml multiple-dose vials containing 40 mg/ml of gentamicin
base in aqueous solution at a pH of 4,5, for intramuscular/intravenous
administration.
GARAMYCIN Pediatric Injectable 10 mg/ml: GARAMYCIN Pediatric
Injectable is packaged in 2 ml multiple-dose vials containing 10 mg/m l
of gentamicin base in aqueous solution at a pH of 4,5, for
intramuscular/intravenous administration.
They are both heat stable and do not require refrigeration.
Full information and references are available on request.
‘ Reg. T.M.

Injectable IM /IV

Garamycin
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SILICONE-TREATED
BRAIDED POLYESTER SUTURES

The suture that gives you
tighter control in:
• cardiovascular surgery
• thoracic surgery
• plastic surgery
TI»CRON passes through tissue and
prosthetic grafts like a monofilament be
cause of its smooth silicone finish. Gives
easy run down of knots and good knot se
curity. TI*CRON has a soft, pliable
“ hand” . Its smooth surgical construction
gives you the control you need. TI«CRON
suture fibers rarely fray or fracture. You
get a strong suture strand offering greater
security for you and your patient.
Sketch is graphic
representation

of

ThCRON silicone
Treated Polyester
Suture at 500 X
magnification.

CYANAMID OF CANADA L IM IT E D
* Registered Trademark
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Books Received
Books are acknowledged as received, but
in some cases reviews will also be made
in later issues.
An Aid to Clinical Surgery. Peter R. Scott. 324
pp. Illust. Churchill Livingstone, Edinburgh;
Longman Canada Limited, Toronto, 1971. $14.50.
Angiography. Techniques and Procedures.
Joseph E. Whitley and Nancy O’Neil Whitley.
122 pp. Illust. Warren H. Green, Inc., St. Louis,
1971. $12.50.
Aspirin, Platelets and Stroke. Background for a
Clinical Trial. Compiled and edited by William
S. Fields and William K. Hass. 153 pp. Illust.
Warren H. Green, Inc., St. Louis, 1971. $10.50.
Atlas of the Histology of Brain Tumors. Klaus
J. Ziilch. 261 pp. Illust. Springer-Verlag, New
York, 1971. $22.60.
Les Entretiens de Bichat 1971. Chirurgie. Specialites. P.-L. Chigot and A. Beilin. 408 pp.
Expansion Scientifique Frangaise, Paris, 1971.
Price not stated.
Fundamental Skills in Surgery. 2nd ed. Thomas
F. Nealon, Jr. 327 pp. Illust. W. B. Saunders
Company, Philadelphia; W. B. Saunders Company
Canada Limited, Toronto, 1971. $12.10.
Nouvelle Pratique Chirurgicale Ulustree. Fasci
cule IV. Deuxieme Serie. Jean Quenu. 251 pp.
Illust. Doin, Editeurs, Paris, 1971. Price not
stated.
Occult Traumatic Lesions of the Cervical
Vertebrae. Martin S. Abel. 148 pp. Illust. Warren
H. Green. Inc., St. Louis, 1971. $12.50.
The Orthopaedic Management of Spina Bifida
Cystica. Malcolm B. Menelaus. 116 pp. Illust.
E. & S. Livingstone, Edinburgh; Longman
Canada Limited, Toronto, 1971. $10.75.
Outline of Orthopaedics. 7th ed. John Crawford
Adams. 476 pp. Illust. Churchill Livingstone,
Edinburgh; Longman Canada Limited, Toronto,
1971. $8.00.
Progress in Pediatric Surgery. Volume 2. Edited
by P. P. Rickham, W. Ch. Hecker and J. Prevot.
178 pp. Illust. University Park Press, Baltimore,
1971. $12.50.
Scoliosis and Growth. Proceedings of a Third
Symposium held at The Institute of Diseases of
the Chest, Brompton Hospital, London, on 13th
November 1970. Edited by P. A. Zorab. 154 pp.
Illust. Churchill Livingstone, Edinburgh; Long
man Canada Limited, Toronto, 1971. $14.50.
Selected Aspects of Skin Cancer. Proceedings
of the 16th Clinical Conference, November 6,
1970, Ottawa Civic Hospital and Ottawa General
Hospital. Edited by M. Hummell and J. O.
Godden. 135 pp. Illust. Ontario Cancer Treatment
and Research Foundation, Toronto, 1971. Free.

ROYAL VICTORIA HOSPITAL

PROBLEMS IN
GENERAL SURGERY
APRIL 5, 6, 7, 1972
T h is C o u r s e is d e s i g n e d fo r the s u r 
g e o n in a ctive p ra ctice . S e s s i o n s w il l
i n c lu d e
general
surgery,
com m on
p e rip h e ra l v a s c u la r s u rg e ry a n d c o v 
e r a g e o f p re a n d p o s t - o p e r a t i v e care ,
l e a c h i n g m e t h o d s to be utilize d a r e
w a r d r o u n d s , c a s e p r e s e n t a t io n , o p e r 
a t i v e clinics, s e m i n a r s a n d lectures.
Recent a d v a n c e s w il l be e m p h a s i z e d .
E n r o l m e n t is lim it e d to forty -five .
FEE: $ 1 0 0 . 0 0
For further inform ation, write to:

The Secretary,
P o st-G ra d u ate Board,
R o y a l Victoria Hospital,
M o ntre al 112, Quebec.

(Continued from Adv. page 23)
SHOCK. A Physiologic Basis for Treatment. Alan
P. Thai, E . B. Brown, Jr., Arlo S. Hermreck
and Hugh H. Bell. 304 pp. Illust. Year Book
Medical Publishers, Inc., Chicago, 1971. $15.25.

A. P. Thai, a surgeon, E. B. Brown, a physi
ologist, H. H. Bell, a cardiologist and A. S.
Hermreck, a surgeon, accomplish their mis
sion in establishing a physiologic basis for the
treatment of shock.
The concept of shock as a response of the
body to life-threatening adverse stimuli is
nicely developed in a historical section,
further elaborated in a section on pathophysi
ology and finally applied very practically in
the section on treatment.
This text is much more comprehensive than
previous texts on the subject and has a con
stant clinical focus.
The systemic response to shock is particu
larly complete and includes a detailed con
sideration of the coagulation and antifibrin
mechanisms. The lung, of great importance in
shock, rightly occupies 50 of the 300 pages of
this text. However, one would like to see more
than one-half page on the liver. Newer con
cepts of the regional distribution of ventila
tion and perfusion and the ventilation-to-perfusion ratio are clearly presented. Case presen(Continued on Adv. page 28)
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(C on tin u ed from Adv. p a g e 27)

tations are used effectively throughout the
text.
Much of the content of this volume can be
found in a standard textbook of physiology but
these familiar concepts, here related to the
specific problem of the patient in shock, en
hance our understanding of both the physi
ology and the clinical problem.
The reader might summarize his impression
of this text as the applied physiology of the
acutely ill patient. The publication will be of
interest to surgeons, internists and indeed all
who might be required to treat a patient
in shock.
SURGICAL TECHNIQUES. Herbert Haxton.
199 pp. Illust. John Wright & Sons Ltd., Bristol;
The Macmillan Company of Canada Limited,
Toronto, 1970. $7.95.

This text is of limited usefulness in that it
records the views of one surgeon and how he
performs his duties. There is no bibliography,
although frequent references are made to the
work of others and their techniques.
This book is not recommended to students
and house staff because it presents many con
troversial areas which only the experienced
surgeon can evaluate.

THIRD NATIONAL WORKSHOP IN
SCIEN TIFIC WRITING
The Division of Postgraduate Medical
Education of the Faculty of Medicine,
University of Toronto and the Hospital for
Sick Children, Toronto, will present the
Third National Workshop in Scientific
Writing from March 27-29, 1972.
The workshop will cover the following:
Writing for Scientific and Medical Journals,
The Case Report, How to Develop Effec
tive Tables and Graphs, and Planning a
“How to” Movie.
The registration is limited to 24 and the
closing date is January 20, 1972. The fee
for the course is $100.00. Participants will
receive their course assignments at the time
of registration. Further information may
be obtained from: The Director, Division
of Postgraduate Medical Education, Faculty
of Medicine, University of Toronto, Toronto
5, Ontario.

BLOOD
FLOW ?

f o r c lin ic a l
a p p lic a tio n s

I

• Designed for clinical O R.
or cath lab use
• Easily applied handletype probe
• Patient safety assured
through isolation circuitry
• Simple to operate minimum controls - direct
meter readout in milliliters
per minute

BLI
Biotronex Laboratory has eliminated
the guesswork in evaluating the effective
ness o f an aorto-coronary vein bypass.
The BL-603 Clinical Blood Flowmeter
provides a simple, yet effective method
o f determining graft patency prior to
surgical closure.
The BL-603 is n o t a new instrument;
i t is simply an extension o f a device
which has been thoroughly proven in
hundreds o f research applications
throughout the world. It is depend
able; designed to highest safety
standards; simple in operation; precise
in measurement - a complement to
modern day cardio vascular surgery.

Biotronex Laboratory, Inc.
9153 Brookville Road

Silver Spring, Maryland 20910

Phone: 301/588-6400
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Two programs for surgeons, one on
trauma and the other on controversial A S T R A P H A R M A C E U T I C A L S ( C A N A D A ) LTD.
X y lo c a in e ................................................... 1 7, I 8
areas in surgery, will he presented by
A Y E R S T LA B O R A T O R IES, D IV . O F AYERST,
U.C.L.A. Extension’s Continuing Educa
M c K E N N A & H A R R I S O N L IM IT E D
tion in Health Sciences and the U.C.L.A.
Fluothane............................................................6
School of Medicine in March 1972, at the
El Mirador Hotel in Palm Springs, Cali
BA XT ER LA BO R A T O R IES O F C A N A D A
fornia.
LIM ITE D
The first, “A Multidiscipline Symposium
V i a f l e x ..................................................... 2 0 21
Workshop for Physicians on Management B I O T R O N E X L A B O R A T O R Y , I N C .
of Trauma will be held from March 22Blood Flow B L I.................................
28
25. Among the topics for discussion will B R I S T O L L A B O R A T O R I E S O F C A N A D A
LIM ITED
be ‘ The Surgeon in the Emergency Depart
Kan trex
54,55
ment; Pitfalls and Progress with Central
Venous Catheterization”, “Current Con B U R R O U G H S - W E L L C O M E & C O . ( C A N A D A ) LTD.
N-I.S................................................................. .
cepts of Hypovolemic Shock”, “Principles
in Management of Pelvic and Extremity
Fractures”, “Bleeding and Clotting Prob D A V I S & G E C K
D e x o n .........
Out si de Back C o v e r
lems with Massive Trauma” and “Respira
Min oc in ...........
............................7
tory Insufficiency Syndrome”. Other ses
Ti-Cron
26
sions will deal with “Penetrating Wounds
of the Thoracic Inlet”, “Cardiac Wounds”,
“The Role of Angiography in Evaluating E A T O N L A B O R A T O R I E S
Furacin U re th r al .........
............................9
Abdominal Injuries”, “Controversies in the
E T H I C O N S U T U R E S LTD.
...................4
Management of Hepatic Injuries” and “The
Pr ole ne .................
Inside Back C o v e r
Diagnosis of Hemoperitoneum by Lavage”.
The second, “The Ninth Annual U.C.L.A.
g e ig y p h a r m a c e u t ic a l s
Seminar on Controversial Areas in Surgery”,
T a n d e a r l l...............
22
will be held from March 25-29 and will
G L A X O - A L L E N B U R Y S ( C A N A D A ) LTD.
present discussion at a level of interest to
C e p o r a n ...........
2
the well-trained surgeon.
Topics will include “Cancer and Im H O L L I S T E R L I M I T E D
munology”, “Breast Lesions: Lobular, Can
O s t o m y ..............
........................ 8
cer and Management of Early Stage I
Cancer”, “Soft Tissue and Skeletal Sar P A R K E , D A V I S & C O M P A N Y L I M I T E D
coma”, “Management of Problems of Ile
V i - D r a p e ..........
.........
.16
ostomy and Colostomy”, “Melanoma”, P R O F E S S I O N A L O R T H O P A E D I C S U P P L I E S
“Cholangiography and Cancer of the Bile
LIM ITED
........................ 15
Duct”, “Pelvic Exenteration for Carcinoma
of the Cervix or Rectum”, “Liver Scanning R O B I N S C O M P A N Y O F C A N A D A LTD., A . H.
All be e with C ......................... ........................ 3 0
and Its Role in Surgery”, “Management of
Pulmonary Metastatic Disease”, “Intra R O Y A L V I C T O R I A H O S P I T A L
27
venous Therapy for Resuscitation and
Maintenance” and “Angiography in Trau S C H E R I N G C O R P . LTD.
G a r a m y c in Injection.................
ma: Essential or Investigative?”
24, 25
The course chairman will he Wiley F.
Barker, M.D., Professor of Surgery at the T R A V E N O L L A B O R A T O R I E S A R T I F I C I A L
O R G A N S D IV IS IO N S
School of Medicine.
E P O ...............
12, 13
Further information may be obtained
from the Department of Continuing Educa
tion in Health Sciences, University Exten U P J O H N C O M P A N Y O F C A N A D A LTD., T H E
G e l f o a m ...............
Inside Front C o v e r
sion, U.C.L.A., Los Angeles, CA 90024 |
Lincocin..................
1 0, 1 1
U.S.A.
S o l u - M e d r o l ............
6 0 , 19
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The experts report: “ The importance of the 13Vitamins and Vitamin C in the healing of wounds
is well known.’’1 . . the traumatic experience
of an operative procedure may induce relative
vitamin deficiency states.” 2 And unbalanced
diets or inadequate food intake before hospitali
zation and during convalescence can put an
even greater physiological strain on the patient.
That’s wnere Allbee with C-550 comes in.
With its more-generous-than-ever amount of
Vitamin C plus the B Vitamins, it amply fulfills
increased requirements and compensates for
deficiencies. So it builds up pre-operative pa
tients and helps speed post-operative recovery.

T

Formula:
Thiamine mononitrate (Bi), 15
mg.; Riboflavin (B2), 10 mg.; Pyridoxine hydrochloride (§6), 5
mg.; Niacinamide, 50 mg.; Cal
cium d-pantothenate,10 mg.;
Ascorbic acid (C), 550 mg.
Available at pharmacies in bot
tles of 30, 100 and 500 on your
prescription or recommendation.
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